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1
General introduction
Bacteria
Bacteria are unicellular organisms that range in size from 0.5 µm to about 20 µm.
They are subdivided into two classes according to the Gram-staining (Popescu & Doyle,
1996). Gram-positive and Gram-negative bacteria differ in the composition of their cell-
envelope. Both classes contain an inner membrane with a cross-linked peptidoglycan
layer on top of it. In Gram-positive bacteria this layer is thicker and forms the outer
surface of the bacterium, whereas Gram-negative bacteria have an additional membrane
at the outside, which is called the outer membrane (Figures 1.1 and 1.2).
Whereas most bacteria pose no threat to human health, a number of them can be
pathogenic (Table 1.1), causing infectious diseases. A number of these infections can be
prevented by the administration of vaccines, non-toxic antigens derived from the
causative bacterium, that activate the host humoral immune system. In addition, due to
the wide use of antibiotics since the 1950s, bacterial infectious diseases ceased to be a
major threat to public health in the western world. In the last two decades, however, it
has become clear that bacterial infectious diseases are all but eradicated.
The emergence of drug-resistance in pathogenic bacteria is an important cause of the
reappearance of infectious diseases in the developed world. Tuberculosis is a striking
example of an infectious disease which had almost been eliminated but which
reappeared, leading to many deaths worldwide (Zumia & Grange, 2001). This
reappearance was due to the development of M. tuberculosis strains that were multidrug-
resistant as a result of the uncontrolled use of antibiotics. Another example is the
methicillin-resistant Staphylococcus aureus (MRSA) strain, which causes considerable
problems in many hospitals (Haddadin et al., 2002).
Due to the growing mobility of the world population, as well as the increasingly
massive character of many manifestations the risk of outbreaks has also significantly
increased. In The Netherlands for example, there have been recent outbreaks of
Legionnaires disease (Hoepelman, 1999), caused by Legionella pneumophila and
meningococcal meningitis, caused by Neisseria meningitidis. A large-scale vaccination
program has been initiated to prevent meningococcal infections in children.
Unfortunately, this vaccine does not provide protection against all pathogenic
meningococcal strains.
These recent developments, challenge new lines of research on novel drugs and
vaccines against bacterial infections. In the case of Gram-negative bacteria, the focus on
outer membrane proteins (OMPs) as therapeutic targets may be a promising strategy for
developing these novel compounds.Three-dimensional structures of proteins have, in a
number of cases, been crucial for the design of drugs (reviewed by Kuhn et al. (2002)).
For example, the structure of HIV-1 protease has led to the development of an inhibitor 
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Table 1.1 pathogenic Gram-negative bacteria
pathogen reservoir main virulence prevention/
disease factors treatment
Borrelia white-footed Lyme disease Outer surface antibiotics in early
burgdorferi mouse/ ticks protein/ adhesins disease (doxycyline,
amoxicille)
Yersinia spp. fleas, rodents, bubonic/ toxins, omptin rodent control,
(e.g. Yersinia cats pneumonic antibiotics
pestis) plague
Pseudomonas water/ soil variety of adhesins/ No vaccine,
auruginosa and plants opportunistic LPS/toxins antibiotic resistance
infections rising
Legionella amoebae in soil Legionnaires proteolytic no vaccine,
pneumophila and water/ disease enzymes antibiotics
air-conditioning
Helicobacter human stomach gastric ulcers adhesins/ no vaccine/ 
pylori toxin/LPS antibiotics
Vibrio cholerae infected humans cholera toxin no vaccine
Salmonella human carriers, typhoid fever/ adhesions/ LPS vaccine
species livestock gastroenteritis against S. typhi
animals antibiotics
Escherichia coli human colon diarrhea/ adhesions/ antibiotics,
urinary tract OmpT/ antibiotics are not
infections/sepsis toxins used against 
and meningitis diarrhea
Neisseria human throat epidemic adhesions vaccine available
meningitidis and nose meningitis (Opa, OpcA) against some
serotypes/antibiotics 
if administered early
Chlamydia infectected cervical antibiotic 
trachomatis humans infection/ treatment
enfertility
Not all pathogenic bacteria, possible reservoirs, related diseases, virulence factors or prevention
and treatment methods are listed, but a relevant selection is made based on Bacterial
Pathogenesis,A molecular approach by A.A. Salyers and Dixie D.Whitt.
of this protease (Wlodawer & Vondrasek, 1998), which is part of a cocktail of drugs
administered to people suffering from AIDS (Gulick, 2003). Another example is
neuraminidase (Wade, 1997), an enzyme isolated from influenza viruses. Its structure was
crucial for the design of drugs that are used to prevent common flu.Whereas structure-
based drug design is becoming an established method, the development of vaccine
compounds, including peptides, is still mainly performed through classical methods.
Recently, a new approach for vaccine development, which involved a structure-based
design of a putative peptide-vaccine, has proven to be successful in eliciting bactericidal
antibodies in mice (Oomen et al., 2003).
Figure 1.1 Schematic representation of the Gram-negative cell-envelope.
The Gram-negative cell envelope consists of three layers, i.e. the inner membrane, the
peptidoglycan layer and the outer membrane.The inner membrane, also called the cytoplasmic or
plasma membrane, is composed of a bilayer of phospholipids. Between the inner and the outer
membranes in Gram-negative bacteria a fluid gel-like zone is present, called the periplasmic space.
This space contains a cross-linked peptidoglycan layer and many soluble proteins involved in
processes such as protein secretion and the uptake of nutrients. Like the inner membrane the outer
membrane also consists of an inner leaflet and an outer leaflet. However, the lipid bilayer of the
outer membrane has an asymmetric organization. It is composed of phospholipids  (70-80%
phosphatidylethanolamine, 20-30% phospatidylglycerol, and cardiolipin) and lipoproteins in the
inner leaflet and mainly lipopolysaccharides (LPS) and sometimes also phospholipids in the outer
leaflet, such as in N. meningitidis.
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Figure 1.2 Lipopolysaccharide.
A) Lipopolysaccharide (LPS) from Escherichia coli strain K-12. LPS is built up of three components,
the lipid A part, the core region and the O-antigen.The core region can be divided into the inner
and the outer core. The O-antigen is not present in Escherichia coli strain K-12 and some other
Gram-negative bacteria. GlcNac = N-acetyl-D-glucosamine, Kdo =  3-deoxy-D-manno-oct-2-
ulopyranosonic acid, Hep = L-glycero-D-manno-heptose, Glc = D-glucose, Gal = D-galactose, P =
phosphate or aminoethyl phosphate. N. meningitidis LPS, which is also referred to as lipooligo-
saccharide  (LOS), contains a shorter tail of core carbohydrates than E. coli. LPS B) Structure of
the Lipid A part of LPS.The dotted line indicates where the core sugars are attached.
Escherichia coli 
Escherichia coli are Gram-negative rods and contain flagella that are necessary for
motility. Classification of E. coli strains is based on the reactivity of highly variable
bacterial surface molecules with different antibodies (Orskov & Orskov, 1992).The O-
antigen of LPS identifies the serogroup of the strain and the H-antigen of flagella
identifies the serotype. Some E. coli strains contain a polysaccharide capsule (the K-
antigen), which is also used for classification. Most E. coli strains are nonpathogenic and
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are commensally present in human intestines. E. coli can grow under aerobic and
anaerobic conditions and do not posses very special nutritional requirements.Therefore,
E. coli has been used as a model organism for studying many biological phenomena. A
number of different E. coli strains, however, can cause diseases, including diarrhoea,
dysentery, kidney failure, urinary tract infections, septicaemia, pneumonia and meningitis.
For example, the production of powerful endotoxins by serotype O157:H7 has been
found to be an important cause of severe diarrhoea (traveller’s diarrhoea) and kidney
failure (Peacock et al., 2001)
Uropathogenic E. coli strains (UPEC) are responsible for 70-95% of urinary tract
infections acquired outside hospitals (Mulvey et al., 2000). The ability of these E. coli
strains to adhere to the bladder mucosae in order to colonize the bladder is thought to
be a key feature of such strains, because non-adhered bacteria are discharged from the
bladder via urination before they can multiply in large quantities. In addition,
uropathogenic E. coli strains multiply much faster than other E. coli strains in urine, again
facilitating the colonization of the urinary tract (Gordon & Riley, 1992). Possibly,
uropathogenic E. coli are resistant to bactericidal defensins, like protamine, that are
excreted by the epithelial cells of the urinary tract (Stumpe et al., 1998).This resistance
may be mediated by the action of the protease OmpT present in the outer membrane of
E. coli (Stumpe et al., 1998). Other factors involved in virulence of the uropathogenic E.
coli strain include LPS, which induces an inflammatory response, α-hemolysin, which
forms pores in host cell membranes, and the K-antigen capsule, which protects the
bacterium from phagocytosis.
Neisseria meningitidis
The Gram-negative diplococcus N. meningitidis is the main cause of life-threatening
meningitis, which is the inflammation of the meninges, the membranes surrounding the
brain. In addition, infection by N. meningitidis can cause sepsis, leading to a septic shock.
The bacterium is continuously present in the mucosae of the naso-pharynx of
approximately 10% of the population, without causing any symptoms (Pollard & Frasch,
2001). Only when it enters the blood stream, it can cause infection. Meningococcal
meningitis and sepsis can be treated with antibiotics, if recognized early enough.
However, early diagnosis of meningococcal infection is difficult, because patients often
present with non-specific symptoms, such as fever and headaches. Even when treated, the
mortality caused by N. meningitidis infections is 10% and even if people survive, lifelong
complications may remain such as amputations, loss of sight or impaired hearing.
N. meningitidis strains contain a polysaccharide capsule around the outer membrane.
Based on these capsular polysaccharides N. meningitidis strains are divided in 12
serogroups, which are further divided into sub-serogroups. Five of these serogroups,
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designated A, B, C, Y and W-135, account for 90% of the disease-producing isolates
(Cripps et al., 2002). Diseases caused by serogroups B and C predominate all over the
world.Vaccines containing meningoccocal polysaccharides are currently available for A,
C,Y and W-135, but are only effective in children above 2 years of age (Wildes & Tunkel,
2002).Vaccines that are more effective against N. meningitidis serogroup C consist of C-
polysaccharide conjugated to tetanus toxoid or a nontoxic mutant of diphtheria toxin, to
enhance the immunogenicity of the vaccine (Fairley et al., 1996). No vaccine is
commercially available yet against serogroup B, which is responsible for half of the
meningococcal infections in the developed countries. Capsular polysaccharides of
serogroup B cannot be used as a vaccine because they are poorly immunogenic, probably
because these polysaccharides contain sialic acid residues, which are also present on the
surface of most human cells (Moe & Granoff, 2001).
Researchers have started to explore the possibility of using outer membrane vesicles
(OMVs) containing immunogenic outer membrane proteins (OMPs) for vaccine
development (Morley & Pollard, 2001). Much progress has been made using PorA,
derived from different meningococcal B strains, in outer membrane vesicles as potential
vaccine. A hexavalent PorA outer membrane vesicle preparation was shown to elicit
bactericidal antibodies in human (Peeters et al., 1996). PorB and Opc are also being
explored as potential vaccine candidates (Rosenqvist et al., 1995;Wright et al., 2002). A
disadvantage of using the highly immunogenic OMPs, such as PorA, PorB and Opc as
vaccines, is that these proteins are hypervariable in sequence. Hypervariability of certain
genes is caused by the high mutation and recombination rate of N. meningitidis, which
results in the occurrence of novel antigen sequences.As a result, strains with novel antigen
sequences may not be recognised anymore by the antibodies raised against the original
OMPs.Therefore, efforts have been made to identify outer membrane proteins that are
more conserved in sequence. One of the successes has been the identification in 1997 of
a highly conserved OMP, NspA, which is therefore an attractive vaccine candidate
(Martin et al., 1997).
Outer membrane proteins
Bacterial outer membrane proteins (OMPs) perform a range of important functions.
They can form channels, which are involved in the uptake of nutrients and the export of
proteins.They can function as adhesins, which mediate the adherence of bacteria to host
cells. Other OMPs are enzymes, involved in lipopolysaccharide modification,
phospholipid degradation or proteolysis of extracellular proteins. Because OMPs are
exposed at the surface of the bacterium they are potential targets for antimicrobial drugs
and vaccine development.
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Overall structure of OMPs
A number of OMP structures have been solved using X-ray crystallography and, in a
few cases, NMR spectroscopy. These studies have revealed the general architecture of
OMPs  and in addition indicate that, despite the different functions performed by OMPs,
their structures are much less diverse than those of water-soluble proteins.Whereas inner
membrane proteins are solely made up of α-helices with long stretches of hydrophobic
residues, outer membrane proteins exclusively contain next-neighbour anti-parallel β-
strands, forming closed barrels, referred to as β-barrels.
β-Barrels of OMPs come in different sizes and forms (Figure 1.3). Structures of
OMPs solved to date, revealed β-barrels containing 8 up to 22 β-strands (Table 1.2),
assembled as monomer or in some cases, multimers.Viewed from the extracellular side,
the β-strands are arranged in a clockwise fashion around the central axis of the beta-
barrel (Figure 1.4). The tilt angle of the strands with respect to the barrel axis is also
clockwise.The diaphragm of the barrel depends on this tilt, which is on average 45º and
which itself depends on the shear number of the strands. The shear number gives the
number of amino acids the strand goes up when the next neighbour hydrogen bonded
residues are followed until reaching the starting strand again.
In the membrane-spanning region of the β-barrel, all main chain hydrogen bond
donor and acceptors participate in inter-strand hydrogen bonding.Also within the same
region, hydrophobic residues point towards the membrane whereas hydrophilic residues
point to the inside of the β-barrel (reviewed by Schulz et al. (Schulz, 2002). In water-
soluble proteins this is the reverse. Most OMPs contain girdles of aromatic residues at the
membrane boundaries that probably stabilize the position of the protein in the outer
membrane. Furthermore, OMPs contain short turns (called T1,T2, …) at the periplasmic
side of the barrel and long loops (called L1, L2, …) at the extracellular side of the barrel.
The N-terminal and C-terminal regions of the protein are always located at the
periplasmic side.
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Figure 1.3 Structures of OMPs with different sizes. The
hydrophilic/hydrophobic boundaries of the outer membrane are indicated with black
lines.All OMPs are shown as ribbon representations and are at the same scale.The upper
panel shows some E. coli OMP structures, whereas the lower panel shows all OMP
structures known from N. meningitidis.The E. coli OMPs are Maltoporin (Schirmer et
al., 1995), FhuA (Ferguson et al., 1998), OmpT (described in this thesis (Vandeputte-
Rutten et al., 2001)), OmpA (Pautsch & Schulz, 1998) and TolC (Koronakis et al., 2000).
The OMPs from N. meningitidis are OpcA (Prince et al., 2002), NalP (Oomen,
submitted) and NspA (described in this thesis (Vandeputte-Rutten et al., 2003))
Table 1.2 OMPs with known structure.
No. of
β-strands name Species function
8 OmpA Escherichia coli membrane-anchor to
(Pautsch & Schulz, 1998) periplasm 
OmpX Escherichia coli Adhesin
(Vogt & Schulz, 1999)
PagP Escherichia coli LPS modification
(Hwang et al., 2002)
NspA Neisseria meningitidis function not known yet
(Vandeputte-Rutten et al., 2003)
10 OmpT Escherichia coli protease
(Vandeputte-Rutten et al., 2001)
OpcA Neisseria meningitidis Adhesin
(Prince et al., 2002)
12 OMPLA Escherichia coli phospholipase
(Snijder et al., 1999)
TolC Escherichia coli protein transport
(Koronakis et al., 2000)
NalP 
(Oomen et al., submitted) Neisseria meningititidis Autotransporter 
16 porin (Weiss et al., 1990) Rhodobacter capsulatus porin
ompF (Cowan et al., 1992) Escherichia coli porin
PhoE (Cowan et al., 1992) Escherichia coli porin
porin (Kreusch et al., 1994) Rhodopseudomonas blastica porin
porin (Hirsch et al., 1997) Paracoccus denitrificans porin
OmpK36 (osmoporin) Klebsiella pneumoniae
(Dutzler et al., 1999) porin
anion selective Omp32 Comamomonas acidovorans
(Zeth et al., 2000) porin
18 Maltoporin (Schirmer et al., 1995) Escherichia coli porin
Maltoporin (Meyer et al., 1997) Salmonella typhimurium porin
Sucrose specific ScrY porin Salmonella typhimurium porin
(Forst et al., 1998)
22 FhuA Escherichia coli iron-siderophore uptake
(Ferguson et al., 1998)
Ferric enterobacterin Escherichia coli iron-siderophore uptake
receptor (fepA)
(Buchanan et al., 1999)
ferric citrate transporter Escherichia coli iron- siderophore uptake
(FecA)(Ferguson et al., 2002)
Chapter 1
16
Figure 1.4 Topology model and structure of NspA, an example of the architecture
of OMPs.
The view of the topology model (left panel) is from outside the β-barrel. A copy of the N-
terminal strand is placed next to the C-terminal strand. Residues are indicated with one-letter
codes. The residues that point to the outside of the β-barrel are with a grey shaded or black
background, whereas the residues that point to the inside of the β-barrel have a white background.
The hydrophobic/hydrophilic boundaries of the outer membrane are indicated with black lines.
Aromatic residues present at these boundaries are indicated with a black background.The short
periplasmic turns are numbered T1, T2, and T3, whereas the longer extracellular loops are
numbered L1 to L4. Using the copy of the N-terminal strand, the definitions of the shear number
and the tilt angle are shown. In the case of NspA, the shear number is 10.
Transport and insertion into the OM
In vivo, OMPs are synthesized with a leader peptide or signal sequence preceding the
mature protein sequence. This peptide is required for the recognition by the Sec
chaperone system, which transports the unfolded OMPs across the inner membrane
(Danese & Silhavy, 1998) into the periplasm.There, the signal peptide is cleaved off after
which the protein is folded into the outer membrane.Voulhoux et al. recently showed
that Omp85, a conserved 85-kDa outer membrane protein, is likely to play an important
part in this latter process (Voulhoux et al., 2003).The lack of long hydrophobic stretches
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in OMPs is probably related to their requirement for transport across the inner
membrane, which would otherwise be hampered, because the OMPs would get stuck in
the inner membrane.
Recombinant production of OMPs
Determining the crystal structure of proteins heavily depends on obtaining pure
protein in sufficient amounts. For a long time this has been difficult for membrane
proteins, because they are low abundant. Fortunately, many OMPs can be recombinantly
expressed in bacteria, without their leader sequence.This often leads to the formation of
large amounts of inclusion bodies, insoluble protein aggregates in the bacterium, which
consist for more than 90% of the desired protein. Inclusion bodies can be solubilized
using 8M urea and the protein can subsequently be refolded to the native state in an
appropriate detergent solution (Buchanan, 1999). Refolding of OMPs can be monitored
by non-denaturing SDS-PAGE because folded OMPs have different mobility than if they
are unfolded (Beher et al., 1980).This is referred to as heat-modifiability. Expression using
inclusion bodies typically yields milligram amounts of the desired protein of high purity,
which facilitates further purification by means of ion-exchange chromatography. During
all steps of purification, OMPs have to stay in detergent containing solution to keep them
soluble.
OMP structures of E. coli and N. meningitidis
More than half of the OMP structures, which are 22 in total solved to date are from
E. coli. Although many E. coli OMPs have homologous counterparts in other Gram-
negative bacteria, this is not always the case. For example, many important adhesin
molecules, such as Opa from N. meningitidis, are not conserved in E. coli. In addition, for
structure-based vaccine development, it is necessary to determine the structure of the
loops of OMPs, as these are the targets of bactericidal antibodies. OMP loops are
generally not highly conserved. It is therefore not surprising that the number of structures
solved of OMPs from other Gram-negative bacteria is increasing.
Structures of three OMPs from N. meningitidis, OpcA, NalP and NspA, have been
solved. OpcA is an adhesin, which facilitates binding of the bacterium to human cells.
One of the ligands for OpcA is the plasma glycoprotein vitronectin, which adheres to
human cells.The structure of OpcA, which comprises a 10-stranded β-barrel, reveals a
positively charged binding cleft, possibly constituting the binding site for vitronectin
(Prince et al., 2002;Virji et al., 1994).
NalP is a member of the family of autotransporters, which transport their own N-
terminal domain across the OM. This domain, ‘the passenger domain’, is often an
important virulence factor. The crystal structure of the translocator domain of NalP
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revealed a 12-stranded barrel with a central N-terminal α-helix inside (Oomen et al.
submitted). This structure forms the basis for a proposed mechanism for translocation,
which does not require ATP. In this thesis the structure of NspA from N. meningitidis is
discussed.
Outer membrane enzymes
Four different types of outer membrane enzymes have been identified and
characterized to date, OmpT, OMPLA, PagP and PagL. Of the first three, structures have
been solved, which of the structure of OmpT is discussed in this thesis. OMPLA is an
enzyme that breaks down phospholipids presented at the outer leaflet of the OM. In E.
coli, these phospholipids are normally only present in the inner leaflet of the membrane,
but can be translocated to the outer leaflet when the OM is disrupted. The crystal
structures of OMPLA in complex with and without a substrate analogue have been
solved (Snijder et al., 1999).These structures provide detailed insight into the activation,
which is dependent on calcium and dimerization.The catalytic site containing Ser-His-
Asn resembles the classical serine hydrolases catalytic triads, but the contribution of the
asparagine to catalysis is only modest (Kingma et al., 2000).
PagP is an enzyme that transfers a palmitate residue from the sn-1 position of a
phospoholipid to the N-linked 3-hydroxymyristate on the proximal unit of lipid A.This
modification of LPS is thought to provide resistance against anti-microbial peptides. An
NMR structure has been solved for PagP (Hwang et al., 2002). The NMR structure
shows that PagP is an 8-stranded β-barrel, with an N-terminal α-helix, having very
flexible extra-cellular loops.The proposed catalytic site, consisting of a classical Ser-His-
Asp triad is not intact in the structure, but it is proposed that stabilization of the
tetrahedral transition state compensates for the energy needed for substrate binding.
Recently, another enzyme involved in LPS modification has been identified, named PagL
(Trent et al., 2001).This enzyme cleaves off one acyl chain of LPS. No structure is as yet
available for this enzyme.
Proteases 
Proteases, also referred to as proteinases, proteolytic enzymes, peptidases or peptide
hydrolases, catalyse the hydrolysis of peptide bonds. Proteases can be divided into two
categories, exopeptidases and endopeptidases. Exopeptidases act only near the N- or C-
terminini of the polypeptide chains, whereas endopeptidases act in the inner regions of
substrates. Some proteases have a high specificity for certain amino acids, whereas others
are much less specific and cleave at multiple sites. Proteases are involved in a multitude of
processes, such as degradation of unfolded or misfolded proteins, activation of other
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enzymes and protein transport. To date, proteases are classified, based on their catalytic
mechanism, into four major classes. These are serine peptidases, cysteine peptidases,
aspartic acid peptidases and metallopeptidases, named after key residues or cofactor
involved in the enzymatic reaction. Some proteases that contain a threonine as the
nucleophile, are classified as a group in the serine peptidases sub-class, and others that
have a glutamic acid are grouped among the aspartic proteases.
The residues in substrates are numbered according to their position with respect to
the cleavage site (Schechter & Berger, 1967). The residues away from the cleavage site
towards the N-terminal direction are numbered P1, P2, …, and the residues away from
the cleavage site towards the C-terminal direction are number P1’, P2’, …. A similar
numbering exists for the substrate binding sub-sites in the protease.The numbering of
these sub-sites are S1, S2, … and S1’, S2’, ….
Catalysis by serine proteases
Classical serine proteases contain a Ser-His-Asp catalytic triad in a special
rearrangement.The mechanism used by serine proteases involves two major stages, the
acylation stage (stage 1) and the deacylation stage (stage 2) (Figure 1.5). In the absence of
substrate, one of the nitrogens in the side chain of the histidine is protonated.The aspartic
acid stabilizes the proton at the Nε1 position, such that during the first step of acylation
of the substrate, the histidine acts as a base abstracting a proton from the OH-group of
the serine residue, which then performs a nucleophilic attack on the carbonyl carbon of
the substrate.The four atoms bonded to the carbonyl carbon are then arranged as in a
tetrahedron, resulting in a tetrahedral intermediate. The tetrahedral intermediate is
stabilized by binding of the carbonyl oxygen in a positively charged hole, the oxyanion
hole. This positive oxyanion hole, which is usually made up of two backbone amides,
makes the carbonyl oxygen more negatively charged by attracting an electron, whereas
the carbonyl carbon becomes more positively charged and therefore becomes more
vulnerable to nucleophilic attack. In the next step of the acylation stage, the acyl-enzyme
intermediate is formed.The extra electron at the carbonyl oxygen returns to its original
position and the proton at the histidine abstracted from the serine, is donated to the
amine part of the substrate. In the second stage in the hydrolysis of a peptide bond, the
acyl-enzyme intermediate is hydrolysed by water. The amine component diffuses away
from the active site and is replaced by water.The histidine now abstracts a proton from
the water molecule making the water molecule nucleophilic towards the carbonyl
carbon. Like in the first stage, again a tetrahedral transition state is formed, followed by
the release of the acid part of the substrate and donation of the proton of the histidine
back to the serine, regenerating the native enzyme species.
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Figure 1.5 Proposed catalytic mechanism for serine proteases containing the
classical Ser/His/Asp catalytic triad.The dotted lines show hydrogen bonds, whereas the
solid lines are covalent interaction made up of electron pairs.The arrows indicate the movement
of the electron pairs.
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Omptins
Omptins are a family of integral outer membrane proteases present in a number of
pathogenic Gram-negative bacteria. Characterized members of the omptin family
include OmpT and OmpP from Escherichia coli (Kaufmann et al., 1994), Pla from Yersinia
pestis (Sodeinde & Goguen, 1989), PgtE from Salmonella thyphimurium (Grodberg &
Dunn, 1989;Yu & Hong, 1986) and SopA from Shigella flexneri (Egile et al., 1997). A
homology blast in the genomic sequence database yielded additional homologs of
omptins in e.g. Mesorhizobium loti, Salmonella typhi, Salmonella paratyphi, and Leuconostoc
pneumophila, and Yersinia pestis. The omptin family is still growing as the number of
bacterial genomes that is sequenced, is increasing. Interestingly, omptins are not present
in all Gram-negative bacteria, for example Neisseria meningitidis lacks an omptin homologue.
A number of studies have suggested a role for the omptin family in bacterial
pathogenicity. For example Pla from Yersinia pestis the causative agent of bubonic plague,
was shown, by Sodeinde et al., to act as an important virulence factor.They showed that
inactivation of this gene resulted in a million-fold increase of the median lethal dose of
the bacteria for mice. (Sodeinde et al., 1992). In addition, several studies have reported a
positive correlation between the presence of the OmpT gene in E. coli and severe urinary
tract disease as well as neonatal meningitis (Webb & Lundigran, 1996) (Johnson et al.,
2002).
Functions of omptins
Omptins have been implicated in the hydrolysis of various peptides and proteins in
vitro. Many of these include recombinant proteins overexpressed in E. coli that are
degraded by OmpT (Grodberg & Dunn, 1988; Hammarberg et al., 1990; Henderson et
al., 1994; Sugimura & Higashi, 1988;White et al., 1995; Zhao & Somerville, 1993) and
are not likely targets in vivo. However, a number of studies have identified host proteins
or peptides that are related to bacterial invasion and immunity, which are candidate
targets for the omptin family.
Defense against innate immune system
OmpT has been found to cleave the antimicrobial cationic peptide protamine, which
is excreted by epithelial cells of the urinary tract (Stumpe et al., 1998). Likewise, PgtE of
Salmonella typhimurium promotes resistance to α-helical cationic antimicrobial peptides
(α-CAMPs) (Guina et al., 2000). In both cases, the bacterium is protected in this way
against the innate immune system, which is the first line of defense against bacterial
infection. In addition, it was also reported that Pla from Yersinia Pestis cleaves complement
C3, which is the central complement factor, on which all three complement pathways
converge (Sodeinde et al., 1992).
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Plasminogen activation
It is likely that the most important function of Pla is to cleave plasminogen, a property
it shares with OmpT from E. coli (Leytus et al., 1981) and PgtE from Salmonella
thyphimurium.The specific cleavage of the zymogen plasminogen results into the active
protease plasmin, which mediates lysis of fibrin, which is normally deposited around the
bacterium to trap the bacterium after infection. In this way omptins may act to breach
barriers to enhance the spread of the bacterium.This theory is supported by the finding
that intact E. coli cells containing OmpT are capable of dissolving a fibrin film, whereas
an OmpT mutant does not (Lundrigan & Webb, 1992).
Additional functions of Pla
Pla displays additionally coagulase activity, i.e. blood clotting activity (Sodeinde &
Goguen, 1989). Blood clotting in the meal of the flea, which results in ejection of the
meal including the plague bacterium into the host, is an important step in spreading of
the bacterium from rodents to human.Therefore, Pla is most likely also involved in this
process, although the proteolytic target of Pla in this process has yet to be identified. In
addition, an adhesive function for Pla has also been observed (Kienle et al., 1992), since
expression of Pla of Yersinia pestis enhances bacterial attachment to the mammalian
extracellular matrix (Lahteenmaki et al., 1998).
Release of passenger domain of autotranporters
SopA (IcsP) of Shigella flexneri, the bacterium, which causes severe dysentery, has been
found to cleave the extracellular part of (VirG) IcsA, an autotransporter, of which the
transported extracellular domain binds to actin-filaments inside cells. Cleavage of IcsA by
SopA was thought to be responsible for the motility of Shigella flexneri inside host cell
(Egile et al., 1997). However, Shere et al. showed that Shigella flexneri strains lacking the
gene coding for SopA have accelerated motility (Shere et al., 1997). Endogenous OmpT
is able to release recombinant passenger domains by cleavage in the linker region between
the passenger domain and the autotransporter b-barrel domain, which is inserted in the
outer membrane (Klauser et al., 1992; Maurer et al., 1997), but no endogenous
autotransporters have been found to be cleaved by OmpT.
OmpT
The gene encoding for the OmpT protein was discovered in 1976 (Manning &
Reeves, 1976). OmpT is biochemically the best-characterized member of the omptin
family. OmpT expression is temperature dependent, i.e. expression is higher at
temperatures above 30°C, hence the T, which stand for temperature, in the name OmpT
(Manning & Reeves, 1976) (Rupprecht et al., 1983).The mature OmpT protein consists
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of 297 amino acid residues, with a calculated mass of 33.5 kDa (Grodberg et al., 1988).
Proteolytic activity by OmpT has in many cases hampered overexpression and
subsequent purification of recombinant proteins in E. coli. For this reason, novel E. coli
strains, such as the widely used BL21(DE3) strains, were engineered that lack the gene
encoding OmpT (Studier & Moffatt, 1986). Reports on cleavage of recombinant proteins
by OmpT lead to the consensus that OmpT proteolytic activity shows preference for two
consecutive basic amino acids. Using spatially addressed peptide libraries, OmpT substrate
specificity was investigated in further detail, revealing the necessity of a positively charged
residue at the P1 position of the peptide, whereas OmpT has a broader allowance for
residues at the P1’ position, except for negatively charged residues, cysteines, tryptophans
and tyrosines (Dekker et al., 2001).The activity of OmpT is dependent on the presence
of lipopolysaccharide (LPS), which is normally abundantly present in the outer
membrane of gram-negative bacteria (Kramer et al., 2000b). Of the LPS the lipid A part
is the minimal requirement for OmpT activity. Furthermore, the core phosphates are also
important for activity (Kramer et al., 2002).OmpT contains no conserved sequence motif
typical for any of the protease families, making classification of OmpT difficult. Most
commonly used protease inhibitors, including chloromethylketones, EDTA, leupeptin
and antipain do not inhibit proteolytic activity of OmpT (Sugimura & Nishihara, 1988).
However, high concentrations of the serine protease inhibitors diisopropylfluoro-
phosphate (DFP) and phenylmethylsulfonyl fluoride (PMSF), do inhibit OmpT activity
(Sugimura & Nishihara, 1988). Mainly based on these findings, omptins were classified as
a new serine protease family (S18 in the enzyme database (omptins: EC 3.4.21.87)).The
catalytic site of serine proteases typically consists of a serine-histidine-aspartate catalytic
triad. Site directed mutagenesis of the conserved serines and histidines of OmpT and Pla,
resulted in the identification of possible catalytic residues.The S99A mutation in OmpT
reduced catalytic activity approximately 500 times whereas the H212A mutation led to a
reduction in activity of ~10.000 times (Kramer et al., 2000a). OmpT activity was found
to have a pH optimum at high pH (Kramer et al., 2000b). These two findings further
supported the classification of OmpT as a serine protease. Later studies, however,
contradict the earlier findings that the serine protease specific inhibitors PMSF and DFP
can inhibit OmpT, since no effect of PMSF and DFP on OmpT activity could be
detected, even at higher concentrations (Hollifield et al., 1978; Sugimura & Higashi,
1988; White et al., 1995). These conflicting results warranted further research into the
catalytic mechanism used by the omptin family.
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Neisserial surface protein A (NspA)
Neisserial surface protein A (NspA) was identified in 1997 by Martin et al. (Martin et
al., 1997) while searching for a potential vaccine candidate against Neisseria meningitidis.
They immunized mice with different combinations of OM preparations in order to
obtain hybridoma clones secreting mAbs specific for highly conserved surface antigens.
One mAb (Me-1) was selected, because it cross-reacted with all nine meningococcal OM
preparations tested. The mAb exhibited bactericidal activity against all meningococcal
strains tested and passively protected mice against experimental meningococcal infection.
Western blotting experiments indicated that Me-1 recognized protein bands with
apparent molecular weights of 22-kDa and 18-kDa. Both bands appeared to correspond
to a single protein, which was called Neisserial surface protein A (NspA).
NspA is highly conserved in sequence and is present and expressed in all strains of
Neisseria meningitidis and Neisseria gonorrhoeae, tested so far (Cadieux et al., 1999; Martin
et al., 1997; Moe et al., 1999; Moe et al., 2001; Plante et al., 1999).The vaccine potential
of NspA was investigated by using recombinant NspA protein expressed in E. coli
(BL21(DE3)).This recombinant NspA was found to be present in the outer membrane
as well as secreted in the culture supernatant, where it is present in outer membrane blebs
(Martin et al., 1997) (Moe et al., 1999). Martin et al. (Martin et al., 1997) purified the
recombinant NspA from the culture supernatant using affinity chromatography and
showed that this NspA shared enough immunological characteristics with the native
protein, to induce bactericidal antibodies. Moe et al., (Moe et al., 1999) however, found
that recombinant NspA elicited antibodies that cross-reacted with only 65% of 17
genetically diverse meningococcal strains. Only 73% of these strains that were recognized
were susceptible to anti-NspA complement-mediated bacteriolysis. A later study, in
which mice and guinea pigs were sequentially immunized with three doses of OMVs
prepared from genetically different meningococcal strains, showed that an NspA-based
vaccine prepared from protein expressed by Neisseria itself did elicit broadly protective
antibodies (Moe et al., 2002).
Mature NspA protein is a relatively small protein consisting of only 155 amino acids.
Like other OMPs, the NspA protein is heat-modifiable, which explains the observation
that NspA runs as two bands on a SDS-PAGE gel.The 18-kDa band corresponds to the
unfolded protein, whereas the 22-kDa band corresponds to the folded form. NspA shares
significant homology with neisserial Opa proteins (Martin et al., 1997; Moe et al., 1999),
which are important adhesins in N. meningitidis. A number of Opa proteins can bind to
the human CEACAM (carcinoembryonic antigen cell adhesion molecule) family of
receptor glycoproteins, thereby allowing the entry of Neisseriae into human cells (Virji
et al., 1996).The function of NspA has not been discovered yet. NspA does not seem to
be essential for causing bacteremia, as an NspA knockout was highly virulent in infant
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rats (Moe et al., 2001). Nevertheless, the observation that NspA is highly conserved
among different neisserial strains suggests an important function and makes it an attractive
vaccine candidate.
Protein crystallography
Three-dimensional structures of proteins are a valuable tool to study protein
functions, interaction between macromolecules and can be used for drug design.Three
techniques can be used to obtain three-dimensional structural information, X-ray
crystallography, nuclear magnetic resonance spectroscopy (NMR), and electron
microscopy. Most three-dimensional atomic models of proteins are determined using X-
ray crystallography and nuclear magnetic resonance (NMR) spectroscopy. Whereas
NMR-spectroscopy does not require a protein crystal and reveals information about the
dynamics of the molecule, it cannot be used for large protein molecules or complexes and
does not yield structures to a resolution as high as for most crystal structures. Using X-
ray crystallography, structures of large proteins or protein complexes can be solved to high
resolutions (~3.5 Å-~1.2 Å).A striking example of a huge macromolecular complex that
has been solved using x-ray crystallography in recent years is the structure of the
ribosome (Ramakrishnan, 2002). A drawback of crystallography is that the method
requires good quality protein crystals (Figure 1.6), which are not always easy to obtain.
Crystallization of proteins, which requires milligrams of very pure protein, can take place
when they are precipitated very slowly under the right conditions, which have to be
searched for by trial-and-error.
Diffraction theory
Crystals are made up of three-dimensional arrays of identical repeating units, called
unit cells.When protein crystals are placed in an X-ray beam, the X-rays will be scattered
in all directions by the electron clouds of the atoms in the crystal. In analogy with the
scattering of visible light by a two-dimensional grid, due to the repetitive building blocks
(unit cells) of crystals, the scattered waves may be enhanced or completely extincted.The
enhanced waves result in discrete diffraction and can be visualized, using a detector, as
diffraction spots with different intensities that form a regular pattern (Figure 1.7).W. L.
Bragg showed that X-ray diffraction by crystals can be regarded as if it were reflection
from sets of parallel, equivalent planes of atoms in the crystal. When x-rays with
wavelength λ impinge on a set of planes with indices hkl and interplanar spacing d at an
angle θ, reflection at the same angle occurs, only if θ meets the condition 2dsinθ=nλ,
where n is an integer (Bragg’s law). Reflection can thus only occur if the difference of
distance travelled by the X-rays reflected by successive planes equals a whole number
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times the wavelength λ of the incident beam. Using Bragg’s law, the positions of the
diffraction spots on the detector can be used to determine the size and characteristics of
the unit cell. To obtain all possible reflections, the crystal is rotated, to ensure that all
planes have been in reflection orientation.
The X-rays that arrive at the detector can be described by the structure factors (Fhkl),
which is a fourier summation of all atomic scattering factors. Whereas diffraction by
electrons in a crystal can be translated by a fourier transform into structures factors,
structure factors are in turn used to calculate the electron density using again a fourier
transform. In the calculated electron density a protein model can be built.The structure
factor includes the amplitude of the resultant diffracted X-ray waves as well as their
phases.The amplitude of the structure factor can be derived from the measured intensity
of the reflection, whereas, unfortunately, the phase of the reflected X-rays cannot be
measured.This crystallographic problem is referred to as the ‘phase problem’.
Figure 1.6 OmpT crystal in a loop. A crystal is usually placed into the X-ray beam in a loop
and cooled to a temperature of 100K.The bar indicates 50 µm.
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Figure 1.7 A diffraction pattern from a protein crystal. Reflections which form a
regular pattern are visible as discreet dark spots with varying intensities. The white vertical and
horizontal lines are a feature of the detector, which consist of four square Charge Coupled Devices
(CCDs).The broader white horizontal region at the right and the white region in the middle are
caused by the beamstop, which blocks the primary beam behind the crystal.
Phasing
To determine the phase of the structure factor a few methods can be used, e.g.
multiple isomorphous replacement (MIR), molecular replacement (MR), multiple-
wavelength anomalous dispersion (MAD) and single-wavelength anomalous dispersion
(SAD). For multiple isomorphous replacement (MIR),which is the most classical method
for determining phases in protein crystallography, a native crystal and at least two crystals
with heavy atoms bound to the protein have to be measured. The differences of the
intensities between the native and other diffraction patterns are caused by the heavy
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atoms and can be used to determine the position of the heavy atoms using the Patterson
function, and subsequent phase determination. As the name isomorphous replacement
indicates, all crystals measured must be isomorphous, a criterion which is not always easy
to satisfy.
Molecular replacement (MR) is often the most rapid method, but can only be used
if the protein of interest has sufficient structural homology to a protein of known
structure.This method uses the phases of the known structure, first applying a rotation
search and than a translation search.
In recent years, anomalously scattering atoms are exploited for structure
determination using multiple- or single-wavelength anomalous dispersion methods
(MAD and SAD). Anomalous scattering atoms cause the intensities of the Friedel pairs,
h,k,l and –h,-k,-l, which are normally identical, to differ slightly, which provides
information for the calculation of protein phases. Since the anomalous differences are
generally very small, data have to be measured very accurately, which is facilitated by
measuring redundant data.A main advantage of MAD and SAD is that only one crystal
is used to obtain enough information for structure determination. Selenium is often used
as anomalous scatterer, because it can be incorporated into recombinant produced
proteins in the form of selenomethionines, which replace the normal methionines in the
protein. Using MAD with at least three wavelengths, protein phases can unambiguously
be determined, whereas with SAD, which uses data from only one wavelength, the phase
distributions for each reflection are bimodal.To discriminate between the right and the
wrong phases obtained by SAD, density modification, including for example solvent
flattening, is a very powerful tool.An advantage of SAD compared with MAD, is that less
data need to be collected, resulting in less radiation damage to the crystal. Additionally,
usage of a tuneable synchrotron X-ray beamline, which are nowadays overbooked due to
the popularity of the MAD method, is often not required.
The phases determined by these methods together with the intensities of the
reflection are used to calculate an ‘experimental’ electron density map in which the
protein model can be built.The process of model building is validated by the so-called
R-factor, which is a measure of the overall agreement between the amplitudes of the
observed structure factors and those of the structure factors calculated from the built
model. Because this agreement is initially rather poor, due to errors in phase
determination, the structure is refined in an iterative process, such that the R-factor will
decrease. This refinement includes the adjustment of the positional parameters of all
atoms and their thermal vibration, which is given by the temperature factor, also referred
to as B-factor.
General Introduction
29
Scope of this thesis
In this thesis, structural studies are described of two outer membrane proteins, OmpT
and NspA, using X-ray crystallography. OmpT is an outer membrane protease from
Escherichia coli. Although outer membrane protease T (OmpT) has been classified as a
novel serine protease, this classification is controversial. OmpT activity is dependent on
the presence of lipopolysaccharide (LPS), which is a feature of OmpT that has not been
observed for other proteases before.What the exact role of LPS in catalysis is, is unclear.
In order to gain more insight into the catalytic mechanism and into LPS activation we
solved the crystal structure of OmpT, which is described in chapter 2. In order to
identify the catalytic site unambiguously, residues essential for catalysis were identified,
using site directed mutagenesis. Important serines and histidines had been identified
previously, whereas the identification of important aspartic acid and glutamic acid
residues is described in chapter 3. All conserved acidic residues had been separately
mutated into alanines and residual activities were determined for all these OmpT
mutants. On the basis of the results described in chapter 2 and chapter 3 we proposed
a novel catalytic mechanism for OmpT. Because zinc is a potent inhibitor of OmpT, the
crystal structure of a OmpT/Zn2+ complex was solved in order to gain more insight into
the active site of OmpT.This complex structure is described in chapter 4. Chapter 5
describes the crystal structure of another outer membrane protein, Neisserial surface
protein A (NspA) from Neisseria meningitidis. NspA is a vaccine candidate against N.
meningitidis, because it is highly conserved and elicits bactericidal antibodies. A crystal
structure of this protein would provide a possible basis for vaccine development using the
structure-based peptide vaccine design.Additionally, a clue about the function of NspA,
which is as yet unknown, may be derived from the crystal structure. In chapter 6 the
results and conclusions described in this thesis are summarized.
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Abstract
OmpT from Escherichia coli belongs to a family of highly homologous outer
membrane proteases, known as omptins, which are implicated in the virulence of several
pathogenic Gram-negative bacteria. Here we present the crystal structure of OmpT,
which shows a 10-stranded antiparallel β-barrel that protrudes far from the lipid bilayer
into the extracellular space.We identified a putative binding site for lipopolysaccharide, a
molecule that is essential for OmpT activity.The proteolytic site is located in a groove at
the extracellular top of the vase-shaped β-barrel. Based on the constellation of active site
residues, we propose a novel proteolytic mechanism, involving a His-Asp dyad and an
Asp-Asp couple that activate a putative nucleophilic water molecule. The active site is
fully conserved within the omptin family.Therefore, the structure described here provides
a sound basis for the design of drugs against omptin-mediated bacterial pathogenesis.
Coordinates are in the Protein Data Bank (accession No. 1I78).
Introduction
Omptins are outer membrane proteases found in several Gram-negative bacteria and
include OmpT of Escherichia coli (Sugimura & Nishihara, 1988), PgtE of Salmonella
typhimurium (mature part 49% identical to OmpT) (Yu & Hong, 1986), Pla of Yersinia
pestis (50% identical) (Sodeinde & Goguen, 1989), SopA of Shigella flexneri (60% identical)
(Egile et al., 1997) and OmpP of E. coli (72% identical) (Kaufmann et al., 1994). Several
studies have implicated the omptin family in the pathogenicity of these bacteria
(Stathopoulos, 1998).The presence of the ompT gene in clinical isolates of E. coli has been
associated with complicated urinary tract disease (Webb & Lundigran, 1996), a notion
supported by the observation that OmpT cleaves protamine, a highly basic antimicrobial
peptide that is excreted by epithelial cells of the urinary tract (Stumpe et al., 1998).
Inactivation of the gene encoding Pla in Y. pestis, the causative agent of plague, increased
the median lethal dose of the bacterium for mice by 106-fold (Sodeinde et al., 1992).The
role of Pla in pathogenicity might be related to its ability to activate plasminogen, a
feature shared with OmpT (Lundrigan & Webb, 1992). SopA from S. flexneri, the
causative agent of bacillary dysentery, cleaves the endogenous autotransporter IcsA that
has an essential role in the formation of actin tails in host cells, and therefore SopA might
be involved in actin-based motility inside infected cells (Egile et al., 1997; Shere et al.,
1997).Thus, the proteolytic activity of the omptins is probably involved in a variety of
ways in the pathogenicity of these bacteria, ranging from bacterial defence, plasmin-
mediated tissue infiltration to motility inside infected cells.
OmpT is biochemically the best characterized member of the omptins. It
preferentially cleaves substrates between two consecutive basic amino acids (Dekker et al.,
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2001). The protease displays optimal activity at alkaline pH and it is dependent on
lipopolysaccharide (LPS), showing no detectable enzymatic activity towards peptide
substrates in the absence of LPS (Kramer et al., 2000b). Hydrolysis of a fluorogenic
peptide substrate by OmpT was characterized by a specificity constant kcat/Km of
108 s-1M-1, indicating a cleavage efficiency comparable with that of water soluble
proteases such as chymotrypsin (Kramer et al., 2000b).The enzyme does not contain any
conserved active site sequence found in other known protease families. In addition,
commonly used serine protease inhibitors have little or no effect on the activity of
OmpT (Sugimura & Nishihara, 1988). However, because some serine protease inhibitors
weakly affect OmpT activity, the omptins have been classified as novel serine proteases
(family S18) (Rawlings & Barrett, 1994). Site-directed mutagenesis studies appeared to
support this classification, since Ser99 and His212 have been found to be important for
the activity of OmpT (Kramer et al., 2000a).
Here we describe the first structure of an integral outer membrane protease, OmpT
from E. coli, at 2.6 Å resolution. The crystallized protein contained three mutations to
prevent autoproteolytic degradation.Based on the structure,we identified a putative LPS-
binding site and provide support for the omptins constituting a novel class of proteases.
Materials and methods
Protein expression and purification
OmpT, containing the mutations S99A, G216K and K217G in order to abolish
autoproteolysis (Kramer et al., 2000b), was overexpressed without its signal sequence (of
20 residues) in E. coli and refolded as described previously (Kramer et al., 2000b). For
expression of seleno-methionine (Se-Met) containing OmpT, E. coli strain B834(DE3)
(Met-auxotroph, Novagen) containing the plasmid that encodes OmpT (S99A, G216K,
K217G) was grown in new minimal medium (Budisa et al., 1995) supplemented with 0.3
mM L-Se-Met (Acros). Refolded native OmpT and Se-Met OmpT (~200 mg) were
loaded onto a 100 mL Fast Flow S-Sepharose column (Amersham Pharmacia)
equilibrated with buffer A [10 mM Zwittergent 3-12 (Fluka), 20 mM sodium acetate, pH
4.0]. The column was washed with buffer A and proteins were eluted with a linear
gradient of NaCl to 1 M in buffer A.The native protein and the Se-Met derivative were
concentrated to 25 mg/ml in buffer B (1% octyl-β-D-glucopyranoside (OG), 5 mM
sodium acetate pH 4.0) using a second S-Sepharose column and centricon concentrators
(Amicon).After dialysis, samples used for crystallization consisted of 20 mg/ml OmpT in
buffer B containing 2.5 mM potassium chloride.
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Crystallization
Crystallization conditions for native OmpT were screened using the hanging drop
vapor diffusion method at 4 and 20°C. Droplets containing equal amounts (1 µl) of
protein and mother liquor were equilibrated against 0.5 ml of reservoir solution. Sparse-
matrix screens for initial trials were performed using Hampton research screen kits
(Hampton research, CA). After 6 months, one small crystal with dimensions of 0.08 x
0.05 x 0.05 mm appeared at 4°C in 30% (v/v) 2-methyl-2,4-pentanediol (MPD, Fluka),
0.2 M ammonium acetate, 0.1 M sodium citrate pH 5.6. A narrower screening around
this crystallization condition was performed: 28 % (v/v) MPD, 0.5 M NaCl and 0.1 M
sodium citrate pH 5.5 yielded one small crystal per drop within a month. Se-Met OmpT
was produced in order to obtain phases for structure determination. Se-Met OmpT
appeared to crystallize faster and yielded larger crystals than the native protein. After 2
weeks, crystals occurred in 1% OG, 30% (v/v) MPD and 0.3 M sodium citrate pH 5.5.
These crystals grew to maximum crystal dimensions of ~0.3 x 0.2 x 0.2 mm in 3 months.
X-ray diffraction analysis
Crystals were harvested from the droplets with cryo-loops and directly frozen into
liquid nitrogen. X-ray data were collected at 100 K on a CCD detector at ID-14 EH4
beamline at the European Synchrotron Radiation Facility (ESRF) in Grenoble. Native
data were collected to 2.6 Å, using an oscillation range of 0.2º.The crystal belongs to the
trigonal space group P3221, with unit cell parameters a = b = 98.4 Å, c = 165.7 Å, α =
β = 90° and γ = 120°. Crystals have a solvent plus detergent content of 63% (v/v) and
two OmpT molecules in the asymmetric unit.A dataset of a Se-Met OmpT crystal was
collected at λpeak=0.9790 Å to a resolution of 3.1 Å. Data were indexed using DENZO
merged with SCALEPACK (Otwinowski & Minor, 1997) and processed further using
TRUNCATE from the CCP4 suite (CCP4, 1994).A summary of the data collection and
final processing statistics is provided in Table 2.1.
Structure determination and refinement
Using the peak dataset of Se-Met OmpT, all 10 selenium sites were found by direct
methods with the DREAR/SnB package (Weeks & Miller, 1999). Phases subsequently
were calculated using MLPHARE (Otwinowski, 1991) to 3.7 Å resolution.This yielded
an Rcullis (ano) of 0.78 [Rcullis (ano)= Σ(|∆PHobs-∆PHcalc| / Σ|∆PHobs| with
∆PH=FPH(+)-FPH(-)].With density modification in CNS (Brunger et al., 1998), phases
were extended to 3.1 Å resolution. The resulting electron density map allowed the
placement of 80% of the residues using the program O (Jones et al., 1991). The native
dataset was used for refinement from 20 to 2.6 Å resolution. After a rigid body
refinement, iterative model refinement was performed by model building in O, followed
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by simulated annealing and restrained individual B-factor refinement in CNS.The final model
consists of all residues of OmpT in molecule A, residues 11-297 in molecule B, four OG
molecules and 29 water molecules. For the side chains of residues Glu3, Thr4, Glu154,
Glu167,Arg168, Lys216 and Tyr266 of molecule A and Glu33, Glu154, Lys216, and Tyr266 of
molecule B, no electron density was observed.Therefore, these side chains were omitted from
the model.The two monomers in the asymmetric unit pack in a perpendicular orientation to
each other and interact through their hydrophobic transmembrane regions. Intermolecular
Crystal structure of OmpT
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Table 2.1 Summary of data and refinement statistics
Native Se-Met
Data set statistics
resolution limits (outer shell) (Å) 20-2.6 (2.69-2.6) 40-3.1 (3.21-3.1)
space group P3221 P3221
unit cell parameters (Å,°) a = 98.39, a =  97.79,
b = 98.39, b = 97.79,
c = 165.70, c = 165.86,
α = 90, β = 90, γ = 120 α = 90, β = 90, γ = 120
mosaicity (°) 0.1 0.8
oscillation range (°) 0.2 0.5
total oscillation for data set (°) 25 100
total no. of reflections (outer shell) 43,471 (4,352) 107,336 (10,902)
no. of unique reflections (outer shell)1 27,400 (2,766) 17,252 (1,705)
redundancy 1.59 (1.57) 6.22 (6.39)
Rmerge (%) (outer shell)
2 7.4 (26.3) 9.7 (39.5)
completeness (%) (outer shell) 94.3 (97.7) 99.8 (100)
I/σ (I) (outer shell) 8.82 (2.54) 15.48 (4.56)
Refinement statistics
resolution range (Å) 20-2.6
total no. of non-hydrogen atoms 4,734
no. of water molecules 29
no. of β-OG molecules 4
Rwork (%) 23.7
Rfree (%) 28.0
r.m.s.d. bond lengths (Å) 0.007
r.m.s.d. bond angles (º) 1.35
average B-factor (all protein atoms) (Å2) 52.6
1 For the Se-Met dataset the Friedel mates have been counted separately.
2 Rmerge = Σ(|I-<I>|)/Σ(I)
protein-protein interactions in the crystal are predominantly of a hydrophobic nature,
with only one unique hydrogen bond (involving Arg100 in molecule A and the main
chain oxygen of Ile160 in molecule B) and a salt bridge (involving Asp10 in molecule A
and Lys277 in molecule B). In the Ramachandran plot, 85.4 % of the residues are in most
favored regions, with 13.2 % in additionally allowed regions, 1 % in the generously
allowed regions and one residue (Glu190) in a disallowed region. Nε of Arg188 is
hydrogen bonded to the main chain oxygen of Glu190 generating a type II’ β-turn,
explaining the perturbed ϕ,φ-combination of Glu190.The overall temperature factor of
the total structure is 53.2 Å2, with the highest B-factors in the extracellular loops (Figure
2.3).
Results and Discussion
Structure determination
The OmpT structure was determined with the single-wavelength anomalous
diffraction (SAD) phasing method using a Se-Met OmpT crystal, which diffracted to 3.1
Å resolution. The final structure was refined against data to 2.6 Å resolution using a
crystal of OmpT containing natural methionines.The enzyme contained the mutations
S99A, G216K and K217G, to abolish autoproteolytic activity. Additionally, crystals of a
S99A mutant were obtained that diffracted to a lower resolution of 3.2 Å, yielding a map
indicating an identical structure (unpublished results). OmpT was crystallized using 1%
(w/v) OG, 30% (v/v) MPD and 0.3 M sodium citrate pH 5.5. It crystallized in the space
group P3221 with unit cell dimensions a = b = 97.8 Å and c = 165.3 Å. Two OmpT
molecules are present in the asymmetric unit that show a high degree of structural
similarity, with a root mean square deviation (r.m.s.d.) of 0.50 Å for main-chain atoms.
The refined model consists of 584 amino acid residues, four OG and 29 water molecules,
and has a crystallographic R-factor of 23.7% and an Rfree of 28.0% for data in the 20-2.6
Å resolution range.Table 2.1 summarizes the statistics of the crystallographic data and the
refinement. Coordinates and structure factors have been deposited in the Protein Data
Bank with accession No. 1I78.
Overall structure 
The overall structure of OmpT consists of an exceptionally long 10-stranded vase-
shaped antiparallel β-barrel of ~70 Å in its longest dimension (Figure 2.1).The number,
as well as the approximate position of the 10 β-strands,was predicted correctly by Kramer
et al. (2000b).The β-strands have an average length of 23 residues, have a tilt angle of 37-
45° with respect to the barrel axis and have a shear number of 12 (Figure 2.2). Like other
outer membrane proteins (Buchanan et al., 1999; Cowan et al., 1992; Ferguson et al.,
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1998; Koronakis et al., 2000; Kreusch et al., 1994; Locher et al., 1998; Pautsch & Schulz,
1998; Schirmer et al., 1995; Snijder et al., 1999;Vogt & Schulz, 1999;Weiss et al., 1990),
OmpT contains short turns at the periplasmic side of the barrel, long, more mobile loops
(Figure 2.3) at the extracellular part and a hydrophobic band of 25 Å in height flanked
by aromatic residues that determine the position of the molecule in the membrane. On
the extracellular side, OmpT protrudes ~40 Å from the lipid bilayer with the outermost
loops located just above the rim of the LPS core region. Near the top of OmpT, the β-
Crystal structure of OmpT
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Figure 2.1 Overall structure of OmpT. (A) Ribbon representation of OmpT.The extracellular
space is located at the top of the figure, and the periplasmic space is at the bottom. Extracellular
loops are labeled L1-L5.The position of the membrane bilayer is delineated by horizontal lines.
Aromatic residues that are located at the boundary of the hydrophobic and hydrophilic area on the
molecular surface are colored light gray.The proposed catalytic residues are depicted in dark gray
in the extracellular cleft, and the dark gray residues at the side of the barrel show the putative LPS-
binding site. (B) Stereo representation of a modeled LPS molecule at the putative binding site.The
orientation of the OmpT molecule is rotated 90° along the barrel axis, with respect to (A).The
OmpT-LPS model was obtained by superimposing the putative LPS-binding site of OmpT onto
the LPS-binding site of FhuA (Ferguson et al., 2000). LPS (from the FhuA structure) is shown in
thin gray lines.The putative LPS-binding residues in dark gray are labeled.This figure, Figures 2.5
and 2.7 were prepared using Bobscript (Esnouf, 1997) and Raster3D (Merritt et al., 1997).
barrel has a circular diameter of ~32 Å, whereas in the central part the molecular cross-
section is elliptical with dimensions of ~13 by ~26 Å, determined using the Cα positions.
Within the membrane region, the barrel is highly regular, hollow and positively
charged on the inside (Figure 2.4). Above the membrane, the barrel is constricted and
distorted in its hydrogen bonding pattern; seven side chains, i.e. Ser22, Thr73, Arg77,
Gln228, Asn258, Lys259 and Lys260, form hydrogen bonds to main chain atoms in the
β-barrel. This constricted area, consisting of a few layers of predominantly conserved
aromatic residues, forms the floor of a negatively charged groove that harbors the active
site (discussed below).
Putative LPS binding site
In vitro, OmpT displays enzymatic activity only in the presence of LPS (Kramer et al.,
2000b). It is as yet unclear how LPS contributes to OmpT activity, but preliminary
experiments suggest that one LPS molecule per OmpT is sufficient for activity
(unpublished results). Based on the structure of outer membrane protein FhuA from E.
coli in complex with LPS, Ferguson et al. (1998, 2000) identified a structural motif for
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Figure 2.2 Topology model of the OmpT β-barrel.Amino acid residues are given in one-letter
code. Squares represent residues that are present in the β-strands. Side chains of amino acids that
are shaded gray point to the outside of the barrel. Extracellular loops are labeled L1-L5 and
periplasmic turns are labeled T1-T4. Every 25th residue is marked with the corresponding residue
number.The gray area indicates the approximate position of the outer membrane.
LPS binding, consisting of four basic amino acids, which is conserved among pro- and
eucaryotic LPS-binding proteins.Three of the four basic residues are found in a similar
constellation in OmpT (Arg138,Arg175 and Lys226)(Figure 2.1B).The fourth conserved
amino acid (Arg382 in FhuA) is lacking, possibly due to strong bending of OmpT at this
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Figure 2.3 B-factors of the Cα atoms of the two OmpT molecules in the asymmetric unit, i.e.
molecule A (solid line) and B (dashed line). β-Strands are shown by bars that are black within the
membrane spanning region and gray outside this region. The positions of loops and turns are
marked with L1-L5 and T1-T4, respectively.
Figure 2.4 Surface of a cross-section of the β-barrel
(orientation identical to Figure 2.1B). The
extracellular cleft at the top of OmpT is negatively
charged (dark gray), whereas the inside of the barrel at
the membrane spanning region is positively charged
(also dark gray). The positions of the proposed
catalytic residues are labeled.This figure was produced
by the program GRASP (Nicholls et al., 1991).
position.Two additional amino acids that bind LPS in FhuA (Glu304 and Phe302) also
have counterparts in OmpT (Glu136 and Tyr134).The five similar residues in FhuA and
OmpT are at the same height in the barrel and have a r.m.s.d. of 1.1 Å for all atoms.
Based on these similarities, we propose that the above-mentioned residues constitute an
LPS-binding site in OmpT. A model of OmpT with an LPS molecule at the proposed
binding site is shown in Figure 2.1B. The structure of OmpT enables us to test, using
mutagenesis studies, whether these residues are indeed responsible for LPS binding and if
they contribute to OmpT activity.
Active site
OmpT exerts its proteolytic activity in the extracellular medium (Kramer et al.,
2000b).The extracellular part of the molecule contains a large negatively charged groove,
which is consistent with the substrate specificity of OmpT for two consecutive basic
residues (Figure 2.4).All 18 residues in this proposed active site groove are fully conserved
within the omptin family (Figures 2.5 and 2.6). Substitution of serines, histidines and
acidic residues by alanines have resulted in ~10-fold reduced activity for Glu27, Asp97,
Asp208 or His101, ~500-fold reduced activity for Ser99, and ~10,000-fold reduced
activity for Asp83,Asp85,Asp210 or His212 (Kramer et al., 2000a).
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Figure 2.5 Stereo view of a space-filling representation of the active site groove of OmpT,viewed
down the β-barrel axis.All conserved residues in the active site are colored dark gray and labeled.
Residues S99, H101 and D210 are labeled with an asterisk, since they are hidden behind other
residues.The three mutated residues S99A, G216K, K217G are labeled in black.
The structure contradicts the classification of OmpT as a serine protease, since the
previously proposed catalytic residues Ser99 (alanine in the crystal structure) and His212
are too far apart, with a distance of 9 Å between Cβ of Ser99 and Nε2 of His212.
Furthermore, the single histidine located close to Ser99, His101, is only moderately
important for catalysis. The four residues most important for activity form pairs,
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OmpT STETLSFTPD NINADISLGT LSGKTKERVY LAEEGGRKVS QLDWKFNNAA IIKGAINWDL 60
OmpP SDFFGPE KISTEINLGT LSGKTKERVY EPEEGGRKVS QLDWKYSNAA ILKGAVNWEL 57
SopA TTNYPLFIPD NISTDISLGS LSGKTKERVY HPKEGGRKIS QLDWKYSNAT IVRGGIDWKL 60
PgtE ES ALFIPDVSPD SVTTSLSVGV LNGKSRELVY DTDT-GRKLS QLDWKIKNVA TLQGDLSWEP 61
Pla AS SQLIPNISPD SFTVAASTGM LSGKSHEMLY DAET-GRKIS QLDWKIKNVA ILKGDISWDP 61
OmpT MPQISIGAAG WTTLGSRGGN MVDQDWMDSS NPGTWTDESR HPDTQLNYAN EFDLNIKGWL 120
OmpP NPWLSVGAAG WTTLNSRGGN MVDQDWMDSG TPGTWTDESR HPDTRLNYAN EFDLNVKGWF 117
SopA IPKVSFGVSG WTTLGNQKAS MVDKDWNNSN TPQVWTDQSW HPNTHLRDAN EFELNLKGWL 120
PgtE YSFMTLDARG WTSLASGSGH MVDHDWMSSE QPG-WTDRSI HPDTSVNYAN EYDLNVKGWL 120
Pla YSFLTLNARG WTSLASGSGN MDDYDWMNEN QSE-WTDHSS HPATNVNHAN EYDLNVKGWL 120
OmpT LNEPNYRLGL MAGYQESRYS FTARGGSYIY SSEEGFRDDI GSFPNGERAI GYKQRFKMPY 180
OmpP LKESDYRLAI MAGYQESRYS FNATGGTYIY SENGGFRNET GALPDKIKVI GYKQHFKIPY 177
SopA LNNLDYRLGL IAGYQESRYS FNAMGGSYIY SENGGSRNKK GAHPSGERTI GYKQLFKIPY 180
PgtE LQGDNYKAGV TAGYQETRFS WTARGGSYIY -DN-G-R-YI GNFPHGVRGI GYSQRFEMPY 176
Pla LQDENYKAGI TAGYQETRFS WTATGGSYSY -NN-G-A-YT GNFPKGVRVI GYNQRFSMPY 176
OmpT IGLTGSYRYE DFELGGTFKY SGWVESSDND EHYDPGKRIT YRSKVKDQNY YSVAVNAGYY 240
OmpP VGLTGNYRYD NFEFGGAFKY SGWVRGSDND EHYV--RQTT FRSKVINQNY YSVAVNAGYY 235
SopA IGLTANYRHE NFEFGAELKY SGWVLSSDTD KHYQ--TETI FKDEIKNQNY CSVAANIGYY 238
PgtE IGLAGDYRIN DFECNVLFKY SDWVNAHDND EHYM--RKLT FREKTENSRY YGASIDAGYY 234
Pla IGLAGQYRIN DFELNALFKF SDWVRAHDND EHYM--RDLT FREKTSGSRY YGTVINAGYY 234
OmpT VTPNAKVYVE GAWNRVTNKK GNTSLYDHNN –NTSDYSKNG AGIENYNFIT TAGLKYTF 297
OmpP ITPEAKVYIE GVWSRLTNKK GDTSLYDRSD –NTSEHNNNG AGIENYNFIT TAGLKYTF 292
SopA VTPSAKFYIE GSRNYISNKK GDTSLYEQST –NISGTIKNS ASIEYIGFLT SAGIKYIF 295
PgtE ITSNAKIFAE FAYSKYEEGK GGTQIIDKTS GDTAYFGGDA ASIANNNYTV TAGLQYRF 292
Pla VTPNAKVFAE FTYSKYDEGK GGTQTIDKNS GDSVSIGGDA AGISNKNYTV TAGLQYRF 292
Figure 2.6 Sequence alignment of OmpT with other members of the omptin family, i.e. OmpP
of E. coli, SopA of S. flexneri, PgtE of S. typhimurium and Pla of Y. pestis.All fully conserved residues
are shaded gray.The four proposed catalytic residues are depicted with a black background.The
approximate position of the 10 β-strands are indicated by arrows and the extracellular loops are
labeled L1-L5.
Asp83–Asp85 and His212–Asp210, which are located on opposite sides of the active site
groove (Figure 2.7).The distance between the two couples is ~5 Å, determined by the
closest distance between Asp83 and His212. The Asp83-Asp85 couple resembles the
catalytic site of aspartic proteases. On the other hand, the His212-Asp210 couple
resembles the His-Asp pair found in Ser-His-Asp triads of serine proteases. The
observation that OmpT is active at high pH with a pKa of 6.2 (Kramer et al., 2000b)
suggests the involvement of an active site histidine. However, a putative nucleophilic
residue is not present near the His212-Asp210 couple.We propose a mechanism in which
a water molecule (invisible in the electron density map at the current resolution),
positioned between Asp83 and His212, is activated by the His212–Asp210 dyad and
subsequently performs the nucleophilic attack on the scissile peptide bond. A schematic
model of the peptide substrate in the active site is given in Figure 2.7B.
OmpT is highly specific for lysine and arginine at position P1 (nomenclature
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Figure 2.7 Stereo view of the proposed catalytic site. (A) The final 2Fo-Fc electron density map,
at 2.6 Å resolution and contoured at 1σ (orientation identical to Figure 2.1B). Residues are shown
as sticks. (B) The catalytic site viewed from the top down the β-barrel axis.Active site residues are
depicted by ball-and-sticks. Proposed catalytic residues are colored dark gray and the other residues
that are probably involved in substrate binding are colored light gray. The proposed proteolytic
mechanism, in which the His212-Asp210 couple abstracts a proton from a water molecule which
then attacks the main chain carbon, is represented schematically.The putative water molecule is
shown in dark gray and the main chain of a dipeptide substrate in light gray.
according to Schechter and Berger, 1967) and is less specific for residues at P1’, with a
decreasing preference for lysine, isoleucine, histidine and arginine (Dekker et al., 2001).
Furthermore, OmpT shows a high specificity for small hydrophobic residues (isoleucine,
valine and alanine) at P2’, and has a broad tolerance for residues at the P2 position
(Dekker et al., 2001). Given the high specificities for P1 and P2’, we expect well-defined
S1 and S2’ subsites.A deep negative pocket containing Glu27 and Asp208 probably forms
the S1 subsite, which determines the specificity for lysine and arginine at P1 (Figure 2.5).
Approximately 7 Å away from this pocket, the groove is shallow and hydrophobic, with
Met81 and Ile170 located at the bottom of the groove.This region may well form the
S2’ subsite, explaining the high specificity for small hydrophobic residues at P2’.
Interactions between the substrate and the putative S1 and S2’ subsites would position the
scissile peptide bond between the Asp83-Asp85 and His212-Asp210 couples, in
agreement with our proposed catalytic mechanism.
The current model implies a novel proteolytic mechanism, consistent with the
observation that commonly used protease inhibitors do not or weakly affect the activity
of OmpT. Solving the X-ray structure of OmpT in complex with a substrate analogue is
needed to confirm our active site model and to provide more details on the catalytic
mechanism. Since the active site is fully conserved among the omptins, the structure of
OmpT may serve as a template to develop new types of antimicrobial compounds against
omptin-mediated pathogenicity of Gram-negative bacteria.
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Abstract
Escherichia coli outer membrane protease OmpT has previously been classified as a
serine protease with Ser99 and His212 as active site residues.The recently solved X-ray
structure of the enzyme was inconsistent with this classification, and the involvement of
a nucleophilic water molecule was proposed. Here, we substituted all conserved aspartate
and glutamate residues by alanines and measured the residual enzymatic activities of the
variants. Our results support the involvement of a nucleophilic water molecule that is
activated by the Asp210/His212 catalytic dyad. Activity is also strongly dependent on
Asp83 and Asp85. Both may function in binding of the water molecule and/or oxyanion
stabilization.The proposed mechanism implies a novel proteolytic catalytic site.
Introduction
Escherichia coli OmpT (EC 3.4.21.87) is a 33.5 kDa outer membrane protease that
cleaves peptides and proteins preferentially between two consecutive basic amino acids
(Dekker et al., 2001; Grodberg et al., 1988; Kramer et al., 2000b; Mangel et al., 1994;
Sugimura & Nishihara, 1988).The enzyme has been suggested to be involved in urinary
tract disease (Webb & Lundigran, 1996), in DNA excision repair (Sedliakova et al., 1997)
and in the breakdown of antimicrobial peptides (Stumpe et al., 1998), but its actual
biological function remains to be elucidated. OmpT is a member of the omptin family
that includes the proteases PgtE of Salmonella typhimurium (mature part 49% identical to
OmpT) (Yu & Hong, 1986), Pla of Yersinia pestis (50% identical) (Sodeinde & Goguen,
1989), OmpP of E. coli (72% identical) (Kaufmann et al., 1994) and SopA of Shigella
flexneri (60% identical) (Egile et al., 1997). As OmpT, Pla and OmpP lack cysteine
residues, the omptins do not belong to the class of cysteine proteases.The omptin family
appears to constitute a novel class of proteases, since the amino acids conserved within
the omptins are not part of known active site consensus sequences found in serine
proteases, aspartic proteases or metalloproteases (Barrett et al., 1998).This is confirmed by
the observation that OmpT activity is not or only slightly inhibited by commonly used
class-specific protease inhibitors (Sugimura & Higashi, 1988; Sugimura & Nishihara,
1988;White et al., 1995). Significant inhibition of OmpT activity has been observed only
at high concentrations of the serine protease inhibitors diisopropylfluorophosphate (DFP)
or phenylmethylsulfonyl fluoride (PMSF) (Sugimura & Nishihara, 1988).Members of the
omptin family have been classified as serine proteases mainly based on these observations
(Rawlings & Barrett, 1994), even though several experiments have been reported where
DFP and PMSF did not affect the proteolytic activity of OmpT (Hollifield et al., 1978;
Sugimura & Higashi, 1988;White et al., 1995).
In serine proteases, the scissile peptide bond is attacked by a nucleophilic hydroxyl of
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the catalytic serine that is usually activated by a histidine residue (Barrett et al., 1998).To
identify the putative active site serine and histidine of OmpT, we previously substituted
all conserved serines and histidines by site-directed mutagenesis and concluded that Ser99
and His212 are essential active site residues (Kramer et al., 2000a). The activities of
H212A, H212N and H212Q OmpT were reduced by four orders of magnitude.
However, the mutation S99A in OmpT reduced activity only 500-fold, where at least a
10,000-fold reduced activity was expected (e.g. (Carter & Wells, 1988)). It was therefore
emphasized that a role for Ser99 other than performing the nucleophilic attack should
not be excluded.To further examine the active site mechanism, we wished to study the
possible involvement of residues other than serine and histidine. In the classical serine
protease triad, a negatively charged aspartate residue is thought to stabilize the transient
positive charge on the histidine during catalysis (Barrett et al., 1998). Recently, it was
shown that a glutamate is able to perform this function as well (Hakansson et al., 2000).
Conserved acidic residues are thus obvious candidates for being an active site residue of
OmpT. Furthermore, at least one aspartate or glutamate residue is expected to be
involved in substrate binding, since OmpT specifically cleaves peptides between two
positively charged amino acids (Dekker et al., 2001). OmpT contains 36 acidic residues,
of which six aspartates (at positions 43, 83, 85, 97, 208 and 210) and five glutamates (at
positions 27, 111, 136, 193 and 250) are fully conserved within the omptin family (Figure
3.1). Using the same approach as described for the identification of Ser99 and His212
(Kramer et al., 2000a), these 11 residues were replaced by alanines and the residual
activities of the resulting variants were measured. In parallel with these mutagenesis
studies, we solved the X-ray structure of OmpT, which revealed a putative active site cleft
at the top of the extracellular region (Vandeputte-Rutten et al., 2001). Ser99 and His212
are both located in this cleft, but they are separated by 9 Å.The concerted action of Ser99
and His212 was seriously questioned and an alternative mechanism was proposed,
involving an Asp210/His212 catalytic dyad with a water molecule acting as nucleophile
(Vandeputte-Rutten et al., 2001).
Here, we present the mutagenesis data of the conserved aspartate and glutamate
residues and discuss their importance for the proteolytic activity of OmpT. The results
support the involvement of an Asp210/His212 catalytic dyad, suggesting that OmpT
would be the first protease exhibiting this type of catalytic mechanism.
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Figure 3.1 Topology of OmpT (adapted from (Vandeputte-Rutten et al., 2001)). Numbers
refer to amino acid positions in mature OmpT. Residues in β-strands are shown in squares; other
residues are in circles. β-Strand residues pointing to the protein exterior are in shaded squares.
Conserved acidic residues, as well as Ser99 and His212, are in squares with dark edges. The
approximate positions of the outer membrane (OM) and the putative active site cleft of OmpT are
indicated.The N-terminus and the short turns (T1-T4) are localized in the periplasm and the large
loops (L1-L5) face the extracellular side of the membrane.
Materials and methods
Materials
DNA restriction enzymes were purchased from New England Biolabs.
Oligonucleotides were bought from Amersham Pharmacia Biotech. Polyethyleneglycol
tert-octylphenyl ether (Triton X-100) was obtained from Serva and polyoxyethylene
sorbitanmonolaurate (Tween 20) was obtained from Bio-Rad. The fluorogenic peptide
substrate Abz-Ala-Arg-Arg-Ala-Dap(dnp)-Gly (Abz = o-aminobenzoyl, Dap(dnp) = N-
b-dinitrophenyl-L-diaminopropionic acid) was a kind gift of Mr. Ruud C. Cox (Utrecht
University). Anti-OmpT monoclonal antibodies were obtained as described before
(Kramer et al., 2000a). Goat anti-mouse IgG alkaline phosphatase conjugate was
purchased from Promega.All other chemicals were of analytical grade.
Bacterial strains and plasmids
E. coli K-12 strain DH5α (Hanahan, 1983) was used in the cloning procedures. E. coli
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strain BL21(DE3) (Studier & Moffatt, 1986) lacks the ompT gene and was used for
expression. Plasmids pND9 and pND10 (Kramer et al., 2000b) are derivatives of pUC19
(Yanisch-Perron et al., 1985), containing the ompT gene including its own promoter
sequence oriented clockwise and counter-clockwise with the lac promoter, respectively.
All mutations were introduced using PCR according to the manufacturer’s protocol
provided with the QuikChange site-directed mutagenesis kit (Stratagene). The ompT
gene contains only few unique restriction sites. Therefore, four additional unique
restriction sites were introduced to facilitate subcloning of introduced mutations. The
sites XhoI (at Ser89 of mature OmpT), SacII (at Arg144), AgeI (at Arg222) and EagI (at
Ala291) were introduced as silent mutations in plasmids pND10 and pND9, resulting in
plasmids pRAK22 and pRAK23, respectively. Mutations resulting in the substitution of
Asp or Glu by Ala were introduced individually into pRAK22.To facilitate the screening
for introduced mutations, silent mutations resulting in the introduction or deletion of
restriction sites were made concomitantly with the amino acid mutations. After
verification of the correctly introduced mutations by DNA sequencing, all mutations
were subcloned into pRAK23 using the newly introduced restriction sites.The sequences
of the relevant parts of the constructed plasmids were checked by restriction enzyme
analysis and DNA sequencing.
Expression, isolation and analysis of OmpT variants
After transformation by the various plasmids, BL21(DE3) cells were grown overnight
in 10 ml LB medium (Sambrook et al., 1989) with 50 µg/ml ampicillin at 37°C.
Membrane fractions containing OmpT were isolated from the bacteria, as described
before (Kramer et al., 2000a), and solubilized in 200 µl buffer A (0.1% Triton X-100, 50
mM Tris, pH 7.5).The total amount of protein in the isolated membrane fractions was
determined using the Bio-Rad protein assay with bovine serum albumin as a reference.
Samples of membrane fractions corresponding to equal amounts of total protein were
analyzed by Western blotting using anti-OmpT monoclonal antibodies, as described
before (Kramer et al., 2000a).
Enzymatic activity assays
Samples of membrane fractions were diluted in buffer A to appropriate concentrations
(varying from 0.5 µg to 0.2 mg of total protein per ml) prior to OmpT activity
measurements. The internally quenched fluorogenic substrate Abz-Ala-Arg-Arg-Ala-
Dap(dnp)-Gly was used in a fluorimetric activity assay, as described previously (Kramer
et al., 2000b).Assay conditions were 5 µM substrate, 1 mM Tween 20, 5 mM EDTA, 10
mM Tris, pH 8.3. Activity was measured in a fluorimeter using excitation and emission
wavelengths of 325 and 430 nm, respectively.After recording the initial linear increase in
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fluorescence, 20 µg of trypsin was added to determine the fluorescence of completely
hydrolyzed substrate, which enabled quantification of the inner filter effect and allowed
for the calculation of the activity in enzymatic units (U=µmol substrate converted per
min).
Results
Expression of OmpT
Single mutant proteins of OmpT were constructed with the conserved acidic residues
replaced by alanines. BL21(DE3) cells expressing either these alanine variants or wild-
type OmpT were grown in triplicate and membrane fractions were isolated. Cells lacking
a plasmid with the gene for OmpT were used as a control. The fact that isolated
membrane fractions were used instead of purified protein had two important
consequences. An important advantage of using outer membrane fractions was that all
samples contained endogenous lipopolysaccharide, which has been shown to be required
for OmpT activity (Kramer et al., 2000b). Unfortunately the concentration of OmpT in
the samples could not be accurately determined. Therefore, concentrations of total
protein were determined for each sample and used as a measure for the amount of
OmpT.We previously validated this method for serine and histidine variants of OmpT
by showing that the expression levels of these variants were comparable to that of wild-
type OmpT (Kramer et al., 2000a).To check whether this was also true for the aspartate
and glutamate variants, SDS-PAGE and Western blot analysis were performed with all
samples containing equal amounts of total protein. As expected, the expression levels of
the variants and wild-type OmpT were comparable within a factor of three (data not
shown).These differences are acceptable in our studies, since activities reduced by at least
two orders of magnitude are expected when essential residues are replaced. SDS-PAGE
and Western blotting were also used to check the correct folding of the variants.At room
temperature, the presence of SDS is not sufficient to unfold the β-barrel conformation
of OmpT. As a consequence, native OmpT has a more compact shape than the heat-
denatured protein and runs faster on SDS-PAGE gel (Kramer et al., 2000a; Kramer et al.,
2000b).This difference in migration rate between folded and unfolded protein is known
as heat-modifiability, which is generally observed for outer membrane proteins (Heller,
1978).The Western blots showed that all of the 11 active site variants displayed this effect
(data not shown), indicating their proper folding and assembly in the outer membrane.
Activity measurements of OmpT variants
The enzymatic activity of OmpT in the isolated membrane fractions was determined
using a fluorimetric assay. For all variants, membrane fractions of three independent cell
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cultures were measured.The average activities are shown in Figure 3.2.A large spread in
the activities was observed for several variants, which was at least partially due to
variations in expression levels as mentioned above.Variants E111A, E136A, E193A and
E250A displayed enzymatic activities that were comparable to wild- type within a factor
of two. In contrast, variant E27A, as well as all aspartate variants, showed significantly
reduced activities compared to wild-type OmpT. Specific activities of the variants E27A,
D43A, D97A and D208A were reduced 4-17-fold.The strongest decrease was observed
for variants D83A, D85A and D210A, exhibiting at least 10,000-fold lower activity than
wild-type OmpT.
Figure 3.2 Enzymatic activities of OmpT and its variants as measured in a
fluorimetric assay. Average absolute activities of three independent measurements (black bars)
and the corresponding relative activities compared to wild-type OmpT (percentages) were
determined for each variant. See the text for experimental details.
Discussion
The experimental basis for the current classification of OmpT as a serine protease is
weak, as pointed out in the Introduction of this Chapter.To investigate the nature of the
active site, we studied the involvement of acidic residues in substrate binding and/or
hydrolysis by constructing single mutant proteins of OmpT. Substitution of the conserved
residues Asp43, Glu111, Glu136, Glu193 or Glu250 by alanines did not lead to severe
reductions in proteolytic activity (Figure 3.2). Not surprisingly, the side chain of none of
these residues is located in the putative active site cleft (Figure 3.1) (Vandeputte-Rutten
et al., 2001). Deleting either of the remaining six conserved acidic residues, which are all
located inside the highly negatively charged cleft (Figure 3.3) (Vandeputte-Rutten et al.,
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2001), resulted in at least seven-fold lower activity. OmpT preferentially cleaves peptides
between two basic amino acids (Dekker et al., 2001), therefore the anionic nature of the
cleft is probably a major determinant of its substrate specificity. More specifically, we
proposed earlier, based on the crystal structure of OmpT (Vandeputte-Rutten et al.,
2001), that Glu27 and Asp208 may define the high specificity of OmpT for arginine or
lysine at P1 in the substrate (nomenclature as in reference (Schechter & Berger, 1967)).
The mutagenesis data reported here are in good agreement with this proposal. For the
P1’ position, the specificity was less exclusive, but a positively charged amino acid was
preferred there as well (Dekker et al., 2001), likely due to interaction with an anionic
residue of OmpT.Assuming that the substrate has an extended conformation and that the
P1 side chain points towards Glu27 and Asp208, the P1’ chain would be located close to
Asp97. D97A OmpT displayed only 6% residual activity, therefore we propose that Asp97
is responsible for the observed P1’ specificity.A schematic model of a peptide in the active
site is shown in Figure 3.4.
Substituting the aspartate at position 83, 85 or 210 reduced activity at least 10,000-
fold, suggesting that these residues may participate directly in enzymatic catalysis. The
absolute requirement for more than one aspartate is reminiscent of the aspartic proteases,
in which two aspartates activate a nucleophilic water molecule (Barrett et al., 1998).The
relative orientation of Asp83 and Asp85 is in fact similar to that in aspartic proteases
(Vandeputte-Rutten et al., 2001). However, OmpT does not contain the D(T/S)G
consensus sequence of aspartic proteases and it is not active at acidic pH (Kramer et al.,
2000b), while the overall fold is very different from aspartic proteases (Barrett et al.,
1998).A possible role for the Asp83/Asp85 couple is discussed below.The X-ray structure
Chapter 3
62
Figure 3.3 Active site cleft of OmpT 
(adapted from (Vandeputte-Rutten et al.,
2001)). OmpT (ribbon presentation) is
viewed parallel to the barrel axis from the
extracellular side of the outer membrane.
The conserved acidic residues Glu27,
Asp83,Asp85,Asp97,Asp208 and Asp210,
as well as Ser99 (Ala99 in the crystallized
protein) and His212, are represented as
stick model.
of OmpT showed that the relative orientation of Asp210 and His212 is similar to that in
the classical Ser/His/Asp triad and that there is no density at the position where a serine
would be expected (Figure 3.3) (Vandeputte-Rutten et al., 2001). Based on this
information, we recently postulated that OmpT has an Asp210/His212 catalytic dyad
with a water molecule acting as nucleophile (Vandeputte-Rutten et al., 2001). The
observation that Asp210 is indeed essential for activity supports this hypothesis. The
existence of an Asp/His catalytic dyad has been proposed for several enzymes catalyzing
hydrolytic reactions, including phospholipase A2 (Yuan & Tsai, 1999), phosphoesterases
(Knofel & Strater, 1999), endonucleases (Gorman et al., 1997), endocellulases (Russell,
1998) and haloalkane dehalogenase (Pries et al., 1995). Interestingly, it has never been
observed in proteases, implying that OmpT would be the first example of a protease
using this type of catalytic mechanism.As amide bonds are relatively stable, other factors
are expected to facilitate peptide cleavage by activated water. Presumably the
Asp83/Asp85 couple plays a role in the catalytic mechanism, for example by coordinating
the nucleophilic water molecule as proposed before (Vandeputte-Rutten et al., 2001). In
this way, Asp83 and Asp85 would be indirectly involved in activation of the water
molecule, a mechanism that is different from the direct activation of water by aspartates
in aspartic proteases.Alternatively or in addition, a proton shared by the carboxyl moieties
of Asp83 and Asp85 might stabilize the oxyanion intermediate during the reaction. In
agreement with these hypotheses, the mutagenesis experiments show that both amino
acids are required for activity. Further insight in the role of the essential residues Asp83,
Asp85 and Asp210 might be obtained by determining the kinetic parameters kcat and KM
of the corresponding OmpT variants. Unfortunately though, the residual activities of
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Figure 3.4 Schematic two-
dimensional model of a peptide
in the active site of OmpT.
Hydrogen bonds and ionic interactions
are indicated by dashed lines. The
curved arrow represents the
nucleophilic attack on the carbonyl
carbon of the scissile peptide bond.
variants D83A, D85A and D210A OmpT were very close to the detection limit of our
assay, making it impossible to obtain reliable Michaelis-Menten curves for these variants.
The preferred route to detailed elucidation of the active site mechanism would be to
determine the X-ray structure of OmpT in the presence of a peptide substrate.Attempts
to crystallize OmpT in complex with a substrate analogue are currently under way.
Prior to submission of this paper, we became aware of a very recent publication on
omptin Pla of Y. pestis by Kukkonen et al. (Kukkonen et al., 2001), who observed
proteolytic importance for Pla residues corresponding to Ser99, His101, His212, Asp83,
Asp85 and Asp210 in OmpT.They could not settle the exact roles of these residues, but
hypothesized that Pla may contain a Ser99/His212/Asp210 triad (OmpT numbering),
whereas Asp83,Asp85 and His101 were proposed to be involved in substrate interaction
(Kukkonen et al., 2001). Now that we have solved the crystal structure of OmpT and
generated mutagenesis data on all conserved Ser, His,Asp and Glu residues in OmpT, we
have a sound basis for our novel active site model, which does not involve a nucleophilic
serine.The fact that the proposed catalytic residues Asp83,Asp85,Asp210 and His212 of
OmpT have proteolytically important counterparts in Pla, indicates that all omptins likely
use the same catalytic mechanism
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Abstract
Escherichia coli outer membrane protease OmpT is not inhibited by commonly used
protease inhibitors. It is known, however, that zinc has an inhibitory effect on the catalytic
activity.To gain more insight into the catalytic mechanism and the effect of zinc on the
structure of OmpT, we determined the crystal structure of OmpT in complex with
Zn2+. The structure shows that OmpT contains two Zn2+-binding sites, which are
present in the active site.These binding sites are however different in the two molecules
in the asymmetric unit. Interestingly, the structure reveals that in both molecules Zn2+
induces large, and comparable, conformational changes of the extracellular part of the
molecule, which harbours the active site, resulting in a twist of the β-barrel and disorder
of the extra-cellular loops. Furthermore, the finding of a well-coordinated Zn2+ supports
the catalytic mechanism previously proposed for OmpT.
Introduction
OmpT from Escherichia coli is a well-studied member of a family of highly
homologous outer membrane proteases, called omptins. Omptins are implicated as
virulence factors in several Gram-negative bacteria. Important members of the omptin
family include PgtE from Salmonella typhimurium (Yu & Hong, 1986), Pla from Yersinia
pestis (Sodeinde & Goguen, 1989), SopA from Shigella flexneri (Egile et al., 1997) and
OmpP from Escherichia coli (Kaufmann et al., 1994). OmpT itself is implicated in
complicated urinary tract disease (Webb & Lundigran, 1996), and in neonatal meningitis
(Johnson et al., 2002). The activity of OmpT is dependent on the presence of
lipopoplysaccharide (LPS), an abundant component in the outer leaflet of the outer
membrane of Gram-negative bacteria. OmpT shows specific catalytic activity towards
two consecutive basic residues (Dekker et al., 2001), and was classified earlier as a serine
protease (Rawlings & Barrett, 2000). However, known protease inhibitors, such as
diisopropylfluorophosphate (DFP) and phenylmethylsulfonyl fluoride (PMSF), fail to
inhibit the catalytic activity of OmpT (Kramer et al., 2002; Kramer et al., 2000).
Moreover, we recently solved the crystal structure of OmpT (Vandeputte-Rutten et al.,
2001), showing an arrangement of the catalytic site residues that is incompatible with
OmpT being a serine protease. We therefore proposed a novel catalytic mechanism
involving His212, Asp210, Asp83 and Asp85 and a water molecule. In many instances, a
crystal structure of an enzyme with its inhibitor has provided valuable information on the
catalytic mechanism used by the enzyme. It is known that the divalent metal ion Zn2+
inhibits the catalytic activity of OmpT in an uncompetitive manner, with an inhibition
constant of 9.9 µM at pH 7.4 (Mangel et al., 1994). Here we present the structure of
OmpT in complex with Zn2+ to gain more insight into the catalytic mechanism of OmpT.
Chapter 4
68
Materials and Methods
OmpT expression and purification
For crystallization purposes OmpT, without the 20-amino-acid signal sequence,
containing the mutations S99A, G216K and K217G and selenomethionines was over
produced in Escherichia coli strain BL21(DE3), refolded and purified as described
previously (Kramer et al., 2000;Vandeputte-Rutten et al., 2001).
Crystallization and data collection
OmpT crystals were obtained as described before (Vandeputte-Rutten et al., 2001),
in 1% (w/v) octyl-β-D-glucopyranoside (BOG), 300 mM sodium citrate pH 5.5 and
30% (v/v) 2-methyl-2,4-pentanediol (MPD). In one drop containing a crystal, the
mother liquor was gradually exchanged in five steps to 1% (w/v) BOG, 20 mM Tris-HCl
pH 8.0 and 32% (v/v) MPD, in order to obtain a condition optimal for zinc binding.
Subsequently, the crystal was transferred to a drop containing 2 mM of ZnCl2, 1% (w/v)
BOG, 20 mM Tris-HCl pH 8.0 and 32% (v/v) MPD. After one hour of soaking the
crystal was harvested from the droplet using a cryo-loop and directly flash-cooled into
liquid nitrogen. X-ray data were collected at the ID14-EH2 beamline at the European
Synchrotron Radiation Facility (ESRF) in Grenoble at 100K, and with λ = 0.93 Å.The
crystal diffracted to a resolution of 2.55 Å. The space group was P3221 with lattice
constants a = b = 93.2 Å and c = 156.1 Å. For a crystal soaked in 1% (w/v) BOG, 20
mM Tris-HCl pH 8.0 and 32% (v/v) MPD, without ZnCl2, lattice constant were also
determined. Data were processed using DENZO (Otwinowski & Minor, 1997),
SCALEPACK (Otwinowski & Minor, 1997) and TRUNCATE (Collaborative
Computational Project, 1994). A summary of the statistics of datacollection, processing
and refinement is provided in table 4.1.
Structure determination
Attempts to scale the data, obtained for the OmpT/Zn2+ complex with the
previously obtained native data failed. Even when the a and b axis were interchanged, the
data did not scale.As a consequence the crystal structure had to be solved using molecular
replacement. CNS (Brunger et al., 1998) was used to perform the rotation and translation
search using one OmpT molecule including residues A11 to A297 (PDB access code
1I78). The structure was subsequently built using O and refined using REFMAC
(Murshudov et al., 1999).
OmpT inhibited by zinc
69
Table 4.1
Summary of data and refinement statistics
Data set statistics
Resolution limits (outer shell) (Å) 40-2.55 (2.64-2.55)
Space group P3221
Unit cell parameters (Å,°) a = b = 93.15, c = 156.11, α = β = 90, γ = 120
Mosaicity (°) 0.12
Oscillation (°) 0.5
Total oscillation for data set (°) 60
Total no. of reflections (outer shell) 95866 (6463)
No. of unique reflections (outer shell) 26150 (2352)
Redundancy (outer shell) 3.67 (2.75)
Rmerge (%) (outer shell) 6.6 (31.1)
Completeness (%) (outer shell) 98.3 (90.3)
I/σ (I) (outer shell) 13.99 (3.28)
Refinement statistics
Resolution range (Å) 40-2.55
Total no. of non-hydrogen atoms 3449
No.of water molecules 15
No.of BOG molecules 2
Rwork (%) 23.9
Rfree (%) 26.0
r.m.s.d. bond lengths (Å) 0.013
r.m.s.d. bond angles (º) 1.459
Average B-factor (all protein atoms) (Å2) 25.5
Results and Discussion
Structure determination
To gain more insight into the structural basis of Zn2+ inhibition, we determined the
structure of an OmpT/Zn2+ complex. For this purpose, an OmpT crystal was soaked in
2 mM ZnCl2. Data collection and processing statistics are summarized in table 4.1.The
OmpT/Zn2+ complex crystal diffracted to 2.55 Å resolution, which is higher than
obtained for native crystals. Cell dimensions in the crystal from the OmpT/Zn2+
complex are a = b = 93.2 Å and c = 156.1 Å (P3221), whereas in native crystals a and b
are approximately 98 Å and c is approximately 166 Å, with no more than 1 Å deviation.
This means that the cell dimensions are 5.6% shorter for a and b axis and 6.2% shorter
for c axis compared to the native crystals.This remarkable change in cell dimensions is
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not caused by the buffer, in which a OmpT crystal was soaked prior to soaking with
ZnCl2, because the cell dimensions of a native crystal soaked in 20 mM Tris pH 8.0, 32%
MPD and 1% BOG, were not altered (data not shown).
Presumably due to changed cell dimensions, coordinates from the native OmpT
structure could not directly be used in structure elucidation of the OmpT/Zn2+
complex. Firstly, the dataset from the OmpT/Zn2+ complex could not be scaled to the
native dataset, in either a, b, c or b, a, c cell axis orientations. Secondly, rigid body
refinement starting from the coordinates of the native structure yielded R-factors of over
55%. Because structure determination in this way was not successful, molecular
replacement was performed. Like in the native crystals, two monomers, A and B, were
present in the asymmetric unit in the OmpT/Zn2+ crystals. Rigid body refinement
resulted in an R-factor of 44.0%, which dropped to 41.1% after individual B-factor
refinement, with an Rfree of 41.2%.
Inspection of the σA-weighted 2Fobs-Fcalc electron density-map revealed that much
of the electron density was missing for the extracellular loops of both molecules in the
asymmetric unit, whereas the membrane embedded parts of the native OmpT model
fitted well in the electron-density. Figure 4.1 shows molecule A of the OmpT/Zn2+
complex structure with molecule A of the native structure super-positioned on top of it
with a σA-weighted 2Fobs-Fcalc electron density-map calculated with the OmpT/Zn
2+
model found with molecular replacement. Due to electron density missing for the
extracellular loops as well as slightly altered electron density in the active site of the
OmpT/Zn2+ complex, the map was difficult to interpret around the active site of OmpT.
We therefore calculated an anomalous difference map, which revealed eight high peaks
that could be assigned to the seleniums in Met61, Met81, Met131 and Met178 of both
OmpT molecules.A peak expected for the selenium in Met87 was not detected, because
Met87 is located in loop 2, which is disordered. Met81 has substantially shifted from its
original position in the native protein. The selenium from Met81 shifted 4.2 Å in
molecule A and 3.7 Å in molecule B towards the periplasmic side of the β-barrel, while
the Cα shifted only 0.9 Å in molecule A and 0.5 Å in molecule B in the same direction.
At the wavelength we used for data collection a selenium atom emits 3.5 electrons, and
a Zn2+ ion 2.3 electrons. Therefore, the five lower peaks observed in the anomalous
difference map, likely represent the presence of Zn2+ ions. By including the Zn2+ ions
and rebuilding the OmpT/Zn2+ structure the R-factor dropped drastically to 27.8% and
the Rfree to 31.2%.The final structure has an R-factor of 23.9%, an Rfree of 26.0% and
contains two OmpT molecules, 2 BOG’s, 1 citrate and 5 zinc ions. No electron density
was observed for the extracellular loops (residues A30-A38, A85-A100, A147-A170,
A213-A219, A258-A280, B32-B38, B87-B95, B145-B149, B158-B168, B210-B226,
B259-B283), which were therefore omitted from the structure.
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Figure 4.1 A representation of coils of the OmpT/Zn2+ complex structure shown in dark grey and
the native structure shown in light grey.Around the molecular replacement molecule consisting of
all residues from the native structure, the σA-weighted 2Fobs-Fcalc electron density map calculated
after molecular replacement and rigid body refinement is shown. This figure was prepared using
BOBSCRIPT (Esnouf, 1999).
Crystal packing 
In agreement with its decreased cell dimensions, the OmpT/Zn2+ complex crystal
has a more compact crystal packing than the native crystals. The OmpT/Zn2+ crystal
packing and the native crystal packing can be superimposed as in Figure 4.2, in which
the molecules are assigned A, B, A’ and B’. A striking difference between the crystal
packing of the OmpT/Zn2+ complex crystal and the native crystal, is the increase of the
distance between the two-fold symmetry related molecules A and A’.This may be due to
the bending of the extra cellular part of the structure of molecule A of the OmpT/Zn2+
complex with respect to the native structure. Likely the bending is directly caused by
binding of Zn2+ in the active site. Related to the bended structure of molecule A,
molecule B is moved closer to molecule A (Figure 4.2). Due to increased distance
between the two-fold symmetry related molecules A and A’, the four BOG molecule
which are located between them (Figure 4.3A) are also shifted from their original
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positions (Figure 4.3B). In the native crystal form these detergent molecules are nicely
arranged in one plane, whereas in the OmpT/Zn2+ complex crystal the sugar parts of
the two detergent molecules closest to the two-fold rotation axis are stacked on top of
each other. In the native crystal only two hydrophilic interactions were made between
proteins A and B, one hydrogen bond and one salt bridge, which was present between
the loops of molecule A and B (area encircled in Figure 4.2). In the OmpT/Zn2+
complex, however, many hydrophilic contacts are made between the extracellular loops
of molecule A and those of molecule B.
Figure 4.2 Crystal packing of the native crystal shown in light grey and the OmpT/Zn2+ complex
crystal shown in dark grey super-positioned by a origin shift. Molecules are shown as Cα traces
and assigned A, A’, B, B’. The circle shows the position where hydrophilic crystal contacts are
present.
Zinc binding sites
Both OmpT molecules in the asymmetric unit were found to bind two Zn2+ ions in
the active site. Interestingly, in both molecules the Zn2+ binding sites are different (Figure
4.4). In molecule A, one Zn2+ ion is bound between Asp208 and Gln174. For the side
chain of Glu27, which would be in the position to bind to the Zn2+ ion, no electron
density was observed. The second Zn2+ ion is positioned between Asp83, Asp210 and
His212. In molecule B, one Zn2+ ion is present between Glu27 and Asp208.The second 
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Zn2+ is located between Asp83 and Asp85. The different binding of Zn2+ in
molecules A and B could be the result of different crystal  contacts made by these two
molecules.
A remarkable feature of Zn2+ with respect to most other class II divalent cations is
that it can be coordinated by four, five or six ligands,whereas for example Hg2+ and Co2+
are usually coordinated by six ligands. Due to this feature, Zn2+ is often involved in
catalysis.According to Harding et. al. (Harding, 2001) an atom can be defined as a ligand
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A
B
Figure 4.3 β-octyl-glucoside molecules bound between the two symmetry related OmpT
molecules A and A’.A) Ribbon representation of the native OmpT molecule A (behind) with its
two fold symmetry related molecule A’ shown opaque (in front). In dark grey four β-octyl-
glucoside molecules are shown as ball-and-stick. B) A stereo figure of a ball-and-stick
representation of the four β-octyl-glucoside molecules in the native structure shown in light grey
and the four β-octyl-glucoside molecules in the OmpT/Zn2+ complex structure shown in dark grey.
when its distance from the metal atom is within target distance + 0.75 Å.Target chelating
distances to Zn2+ are 2.00 Å for N of His, 2.04 Å for monodentate Asp or Glu, 2.09 Å
for O of H2O and 2.15 Å for bidentate Asp or Glu. In table 4.2 chelating distances
between the Zn2+ ions and the ligands in OmpT are given. According to this table, the
H2O molecules that we inferred from the electron density map, are too distant from the
Zn2+ ions to participate in coordination. However, due to the poor electron density in
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A
B
Figure 4.4 Stereo representation of the active site of the two OmpT molecules in the asymmetric
unit containing the zinc ions. The anomalous map shown at 6σ, shows the positions of the
seleniums and zinc ions. Methionines containing the seleniums and residues that are involved in
binding Zn2+ are shown in ball-and-stick and labelled with one letter codes.The β-barrel is shown
as ribbons.The view is from the top (extracellular side) of the OmpT molecule.A) molecule A and
B) molecule B in the asymmetric unit.
this area, we cannot exclude that additional H2O molecules are present close to the Zn
2+
ions. In addition, the moderate resolution of 2.55 Å of the OmpT/Zn2+ complex crystal
structure, does not allow the accurate determination of chelating distances for the ligands
as listed in table 4.2. In the Protein Data Bank many structures are deposited which
contain Zn2+ ions. In most cases Zn2+ is coordinated by one or more histidines. Some
proteins, of which thermolysin is a well-known example, require Zn2+ for catalysis. In
thermolysin, a Zn2+ is coordinated by two histidines, one glutamic acid (in a bidentate
manner) and a H2O molecule. This kind of coordination represents one of the most
common coordination types for Zn2+. In the crystal structure of the OmpT/Zn2+
complex three of the four zinc ions only have an aspartic, a glutamic, or a glutamine
residue as a ligand, whereas only one Zn2+ coordination involves a histidine as well.
Table 4.2
Zn2+ ligands
Ligand 
Zn2+ OmpT  No. Type Atom Distance (Å)  
Molecule
Zn2+ 1 A 174 Asn Oδ1 2.25   
A 208 Asp Oδ2 2.81  
Zn2+ 2 A 83 Asp Oδ2 1.94   
A 210 Asp Oδ2 2.29   
A 210 Asp Oδ1 2.53  
A 212 His Nε2 2.32  
H2O O 3.24  
Zn2+ 3 B 83 Asp Oδ1 2.13   
B 83 Asp Oδ2 2.97   
B 85 Asp Oδ1 2.44   
B 85 Asp Oδ2 2.88     
H2O O 3.00  
Zn2+ 4 B 27 Glu Oε1 2.05   
B 27 Glu Oε2 2.72   
B 208 Asp Oδ1 1.91     
H2O O 3.09  
It may not seem surprising that Zn2+ binds in the active site of OmpT and inhibits
its activity, because the active site of OmpT contains acidic residues and therefore has
affinity for positively charged ligands. However, if binding of Zn2+ in the substrate
binding pockets on itself is sufficient to cause an inhibitory effect, the inhibition should
be competitive, whereas Mangel et al. previously demonstrated that Zn2+ inhibits OmpT
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non-competitively (Mangel et al., 1994).This implies that the Zn2+ binds strongly to the
catalytic residues, instead of to the substrate binding residues. In the OmpT/Zn2+
complex we observe indeed one Zn2+ ion in both monomers in the asymmetric unit
(Zn2+ 2 and Zn2+ 3 in Figure 4.2) liganded to a few of the proposed catalytic residues
i.e. Asp210, His212, Asp83 and Asp85 (Kramer et al., 2001; Vandeputte-Rutten et al.,
2001). Zn2+ 2 is liganded to Asp83, Asp210 and His212, whereas Zn2+ 3 is liganded to
Asp83 and Asp85. Taking in account that the inhibition is non-competitive and that
Asp210, His212,Asp83 and Asp85 are the most likely catalytic site residues we can assume
that the Zn2+ 2 or the Zn2+ 3 coordination causes the large inhibitory effect of Zn2+.
Furthermore, it is tempting to speculate that Zn2+ 2 has the highest affinity to OmpT of
all four Zn2+ ions present in the active site, because it has a histidine as a ligand and the
highest coordination number, which is five, consisting of the monodentate carboxylate of
Asp83, the bidentate carboxylate of Asp210, the Nε2 nitrogen of histine (His212), and a
water molecule.The observation that Zn2+ 2 and Zn2+ 3 both have Asp83 as a ligand,
strongly suggests that Asp83 is indeed a catalytic residue as was proposed earlier (Kramer
et al., 2001;Vandeputte-Rutten et al., 2001).
Structural changes induced by zinc binding
In the native crystals of OmpT, the two monomers in the asymmetric unit have a
root-mean-square deviation (r.m.s.d.) of only 0.5 Å, and even the loops superimpose
without large deviations (Figure 4.5A), indicating that the structure of OmpT is well
ordered in a certain conformation in the absence of a substrate or lipopolysaccharide
(LPS) (Vandeputte-Rutten et al., 2001). The OmpT/Zn2+ complex crystal structure
clearly shows that the apparent rigid structure becomes disordered, upon Zn2+ binding.
Although the Zn2+ binding sites in both molecules in the asymmetric unit of the
OmpT/Zn2+ complex differ from one another, the structural changes caused by Zn2+
binding show similarities (Figures 4.5B and 4.5C). The β-barrel regions, starting from
residues Phe176 and Tyr185 towards the periplasmic side of the barrel do not change
much with respect to the native structure. The r.m.s.d. between all built Cα atoms of
molecule A of the OmpT/Zn2+ complex and the corresponding Cα atoms in the native
structure was 1.1 Å. In the case of molecule B the r.m.s.d. was 1.8 Å.The extracellular
parts of the barrels are skewed with respect to the native structure and the active sites have
become narrower. In molecule A, the Cα atoms of the proposed catalytic residues Asp83
and His212 have become 2.3 Å closer to one another in the OmpT/Zn2+ complex
structure with respect to the native structure. The distance between the Oδ1 of Asp83
and the Nε2 of His212 shifted from 5.2 Å to 3.4 Å. In molecule B, for residue His212
no electron density was observed. Electron density was also absent for the proposed
catalytic residue Asp210, whereas Asp208 was visible. Therefore, to determine the
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Figure 4.5 Stereo representations of super-positioned Cα traces of OmpT viewed from the
extracellular side. A) Structure of the native molecule A, shown in light grey, and molecule B,
shown in dark grey, overlaid. B) Molecule A of the native structure, shown in light grey, super
positioned on top of molecule A in the OmpT/Zn2+ structure. C) Molecule B of the native
structure, shown in light grey, super positioned on top of molecule B in the OmpT/Zn2+
structure.
A
B
C
difference of the width of the active site in molecule B, we measured the distance
between the Cα atoms of Asp83 and Asp208. In molecule B this distance was 14.2 Å in
the OmpT/Zn2+ complex and 16.3 Å in the native structure. For molecule A these
distances were 12.4 Å versus 15.9 Å. Besides the observation that the active site becomes
narrower, some changes in side-chain orientations in the proposed P2’ binding pocket
occurred. For both Trp44 and the earlier described Se-Met81 the side chain is oriented
downwards with respect to the native structure.These observations imply that OmpT has
a certain degree of flexibility.
In summary, the structure of Zn2+-inhibited OmpT reveals large conformational
changes and a high degree of disorder, when compared to the native structure of OmpT.
Flexibility in the extracellular part of the β-barrel structure, which forms the active site,
likely plays a role in substrate binding and possibly enzyme catalysis. Possibly, LPS binding
affects this flexibility, but the mechanism of activation of OmpT by LPS remains unclear.
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Abstract
The neisserial surface protein A (NspA) from Neisseria meningitidis is a promising
vaccine candidate because it is highly conserved among meningococcal strains and
induces bactericidal antibodies.NspA is a homologue of the Opa proteins,which mediate
adhesion to host cells. Here, we present the crystal structure of NspA, determined to
2.55-Å resolution. NspA forms an eight-stranded antiparallel β-barrel.The four loops at
the extracellular side of the NspA molecule form a long cleft, which contains mainly
hydrophobic residues and harbours a detergent molecule, suggesting that the protein
might function in the binding of hydrophobic ligands, such as lipids. In addition, the
structure provides a starting point for structure-based vaccine design. The atomic
coordinates and structure factors have been deposited in the Protein Data Bank
(accession No. 1P4T)
Introduction
The Gram-negative bacterium Neisseria meningitidis causes life-threatening meningitis
and septicaemia in humans. Based on the immunological characteristics of the capsular
polysaccharides, N. meningitidis strains are divided in 12 serogroups. Strains of serogroups
A, B and C are the predominant cause of meningococcal disease (Frasch, 1989). Effective
vaccines, which consist of capsular polysaccharide conjugated to tetanus toxoid protein
to generate sufficient immunological memory, are now available against serogroups A and
C (Anderson et al., 1994; Costantino et al., 1992). Unfortunately however, the capsular
polysaccharide of serogroup B is poorly immunogenic, making this type of vaccine
ineffective (Mandrell & Zollinger, 1982; Zollinger & Mandrell, 1983). Therefore,
attention has shifted towards the possibility of using outer membrane proteins (OMPs) as
targets for vaccine development (Poolman & Berthet, 2001). OMPs perform a variety of
functions including the following: (a) they may form channels in the outer membrane for
uptake of nutrients or the secretion of proteins; (b) they may be enzymes involved in, for
example, the modification of lipopolysaccharides or in proteolysis; or (c) they may
function as adhesins mediating the interaction of the bacterium to host cells. Despite
these different functions, they appear to share a common fold, i.e. they form trans-
membrane β-barrels consisting of antiparallel amphipathic β-strands. The number of
β-strands in the OMPs, of which the structure has been solved, varies and ranges from 8
to 22 (Schulz, 2002). The best-studied OMPs for vaccine development against N.
meningitidis are the porins PorA and PorB and the adhesin OpcA, which elicit bactericidal
and protective antibody responses (Saukkonen et al., 1987). However, due to the antigenic
heterogeneity of these proteins (Rosenqvist et al., 1993a) or phase-variable expression of
their genes (Rosenqvist et al., 1993b), they are unable to provide protection against all or
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most of the serogroup B strains. Recently, the 18-kDa OMP NspA (Neisserial surface
protein A) has been identified (Martin et al., 1997), which is remarkably conserved
among N. meningitidis and Neisseria gonorrhoeae isolates (Cadieux et al., 1999; Martin et al.,
1997; Moe et al., 1999; Moe et al., 2001; Plante et al., 1999). The function of NspA is
unknown, but it shows considerable sequence similarity with members of the Opa family
of OMPs (Martin et al., 1997), which are important adhesins involved in the entry of
neisseriae into epithelial cells by interacting, for example, with the human
carcinoembryonic antigen cell adhesion molecule (CEACAM) receptors (Chen &
Gotschlich, 1996; Virji et al., 1996). Several studies have shown that NspA can elicit
antibodies that are protective and bactericidal against a wide range of N. meningitidis
serogroup B strains, making NspA an attractive vaccine candidate (Cadieux et al., 1999;
Martin et al., 1997; Moe et al., 1999; Moe et al., 2001; Plante et al., 1999). Recently, Moe
et al. (Moe et al., 2002) showed that sequential immunization using vesicles derived from
different meningococcal strains, thus containing different PorA, PorB and
lipopolysaccharide types, resulted in a protective antibody response against NspA,
underscoring the importance of NspA as a possible vaccine candidate.
To date the crystal structure of only one OMP of N. meningitidis has been solved, i.e.
that of OpcA (Prince et al., 2002), which forms a closed 10-stranded β-barrel. Structural
studies can not only provide insight into the function of OMPs, but they can also reveal
the conformation of epitopes that are recognized by bactericidal antibodies, thus being
helpful for the design of vaccines. Here, we describe the crystal structure of NspA, at
2.55-Å resolution, which shows an eight-stranded antiparallel β-barrel structure with a
hydrophobic groove at the extracellular side harbouring a detergent molecule.
Materials and Methods
Cloning of the nspA gene and expression of the recombinant protein
Genomic DNA of N. meningitidis strain H44/76 was prepared using the Qiagen
genomic preparation kit.The part of the nspA gene encoding the mature domain of the
protein, i.e. without the 19-amino-acid signal peptide, was PCR-amplified with the
primer pair 5’-gctacatatggaaggcgcatccggcttttacg-3’ and 5’-gctaggatcctcagaatttgacgcgcacaccgg-
3’.The PCR product was cloned into pCRII-TOPO (Invitrogen), digested with NdeI
and BamHI, and ligated into pET11a (Novagen), yielding pET11a-NspA. Five-liter
cultures of Escherichia coli strain BL21(DE3) (Novagen), containing  pET11a-NspA, were
grown at 37 °C in L-broth (Tommassen et al., 1983) containing 100 µg/ml ampicillin.At
an optical density at 600 nm of 0.6, 0.1 mM of isopropyl-thio-β-D-galactopyranoside
was added to induce expression of the recombinant gene.After another 4 h of incubation
Crystal structure of NspA
83
at 37ºC, cells were harvested and washed with 600 ml of 0.9% (w/v) NaCl. NspA was
present in inclusion bodies, which were isolated according to Dekker et al. (Dekker et al.,
1995) and solubilized in 8 M urea containing 10 mM glycine, pH 8.0. Residual insoluble
material and membranes were removed by ultracentrifugation (100,000 g for 1 h).
Refolding and purification of NspA
Urea-solubilized NspA protein was folded in vitro by 5-fold dilution into 20 mM
ethanolamine, pH 11, containing 1% (w/v) 3-dimethyldodecylammoniopropane-
sulfonate (DodMe2NprSO3, Fluka) and left overnight at room temperature while
stirring. Refolding was evaluated by SDS-PAGE on gels containing 14% acrylamide
under “semi-native” conditions, i.e. with no SDS in the gel and only 0.03% instead of 3%
SDS in the 3-fold sample-buffer (additionally containing 0.1 M Tris-HCl, pH 6.8, 15.4%
(v/v) glycerol, 7.7% (v/v) β-mercaptoethanol, and 0.008% (w/v) bromophenol blue) and
without heating before electrophoresis. For denaturation, the sample was boiled for 5
minutes with 1% (w/v) SDS. The gels were stained with Coomassie Brilliant Blue for
visualization of the protein bands. To purify the folded NspA, the mixture was loaded
onto a 1-ml mono S column (Amersham Biosciences), pre-equilibrated with 10 mM
DodMe2NprSO3, 20 mM Tris-HCl, pH 8.5 (buffer A). Prior to loading, the pH of the
protein sample was adjusted to pH 8.5 using 1 M HCl.The column was washed with
buffer A, and proteins were eluted with a linear gradient of 0-500 mM NaCl in buffer A,
total volume 50 ml. Fractions containing folded NspA were pooled, diluted 10-fold in
buffer A, and again loaded on a mono S column.The column was washed with buffer B
(20 mM Tris-HCl, pH 7.5, 0.06% (v/v) n-decylpentaoxyethylene (C10E5; Bachem P-
1005)).The protein was eluted with 500 mM NaCl in buffer B and concentrated to 6
mg/ml using Centricon concentrators with molecular mass cutoff of 10 kDa (Amicon).
The protein was dialyzed three times against 10 ml of 0.06% C10E5 prior to
crystallization.
Chemical cross-linking
A 200-µl sample of NspA was incubated at 0.2 mg/ml in 20 mM buffer (either
sodium acetate pH 4.5 or Tris-HCl pH 8.5) containing 1% (v/v) n-octyl-poly-
oxyethylene (O-POE, Alexis), and 5 µl of a 1% stock solution of glutaraldehyde in 1%
(v/v) O-POE was added.The cross-linking reaction was allowed to proceed for 4 h at
room temperature. Subsequently, 100 µl of SDS-PAGE sample buffer was added, and 20
µl of this solution was analyzed by SDS-PAGE.
Analytical ultracentrifugation
Protein molecular weights were determined by sedimentation equilibrium
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centrifugation experiments, using a Beckman Optima XL-A analytical Ultracentrifuge
with absorbance monitoring. Cells contained double-sector charcoal-filled epon
centerpieces and had column lengths of ~8 mm and depths of 3 mm. A protein sample
of 50 µl was used.The sedimentation equilibrium experiments were run at 18,000 rpm
at 20 °C using a loading concentration of ~1.0 mg/ml corresponding to a measured
absorption at 280 nm (A280) of ~0.3 in the cell. Optima XL-A data analysis software
running under the program Microcal Origin version 3.78 (MicroCal Software, Inc.) was
used to calculate the molecular weight. Data were fitted to single component and
monomer/dimer models. A density of 1 g/cm3 was assumed for the solvent plus
detergent, which was 1% (v/v) O-POE and 20 mM Tris-HCl pH 8.5.
Crystallization of NspA and data collection
NspA at a concentration of 6 mg/ml in 0.06% (w/v) C10E5 was crystallized at 4 °C
by the hanging drop vapour diffusion method against a reservoir solution of 12% (w/v)
polyethylene glycol 3000, 0.1 M lithium sulfate, 0.1 M N-(2-acetamido)iminodiacetic
acid (Fluka), pH 6.6, and 2% (v/v) isopropanol.The crystallization drops contained equal
volumes (0.5 µl) of reservoir solution and purified NspA. Crystals were hexagonal and
grew to a size of up to 0.5x0.5x0.1 mm3 in a few days. Crystals were soaked in a cryo
solution containing the reservoir solution, 0.06% (w/v) C10E5, and 20% (v/v) glycerol
and directly cooled in liquid nitrogen. X-ray data were collected at 100 K on a charge-
coupled device (CCD) detector at the ID14 EH1 beamline at the European Synchrotron
Radiation Facility (ESRF). Native data were collected to 2.55 Å resolution using a
wavelength of 0.933 Å and an oscillation range of 1°.The space group of the crystal was
R32 (for the native data set, a = b = 97.37 Å, c = 171.94 Å in the trigonal setting). Due
to the position of the crystal in the loop, which caused the long 3-fold axis to be
perpendicular to the plane of the loop, we measured over 125° to obtain a complete data
set.This resulted in a high redundancy of ~9. Derivative data were collected at 100 K on
the EMBL beamline X11 at DESY (Hamburg).The wavelength was 0.811 Å. Crystals
contained one monomer in the asymmetric unit and had a Vm of 4.74 Å
3/Da,
corresponding to a solvent plus detergent content of 74% (v/v). All diffraction data were
processed using DENZO (Otwinowski & Minor, 1997), SCALEPACK (Otwinowski &
Minor, 1997) and TRUNCATE (Collaborative Computational Project, 1994).
Heavy atom derivatives and phasing 
The structure was finally solved using the single-wavelength anomalous dispersion
phasing method. Initially, molecular replacement was tried because NspA shares sequence
similarity with OmpA and, to a lesser extent, with OmpX.The core β-barrel of OmpA
(Protein Data Bank code 1qjp) was used for molecular replacement. Most residues were
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Table 1. Summary of data and refinement statistics 
Native KAu(CN)2
Data set statistics 
Resolution limits (outer shell) (Å) 40-2.55 (2.64-2.55) 40-3.95 (4.09-3.95)  
Space group R32 R32  
Unit cell parameters (Å,°) a=97.37, b=97.37, c=171.94, a=97.83, b=97.83, c=171.87
α=90, β=90, γ=120 α=90, β=90, γ=120
Mosaicity (°) 0.32 0.49
Oscillation range (°) / Total oscillation (°) 1 / 125 1 / 370
Total no. of reflections (outer shell) 125566 (8944) 98783 (3304)
No. of unique reflections (outer shell)1 10350 (1029) 5388 (549)
Rmerge (%) (outer shell)
2 7.0 (37.5) 5.0 (12.2)
Completeness (%) (outer shell) 98.6 (99.7) 99.9 (100)
I/σ (I) (outer shell) 19.0 (5.2) 23.5 (16.7)
Refinement statistics
Resolution range (Å) 30-2.55
Total no. of non-hydrogen atoms 1278
Rwork (%) 22.2
Rfree (%) 25.8
r.m.s.d. bond lengths (Å) 0.016
r.m.s.d. bond angles (º) 1.77
1 For the KAu(CN)2 dataset the Friedel mates have been counted separately.
2 Rmerge = Σ(|I-<I>|)/Σ(I)
replaced by alanines.The structure could not be refined properly, and therefore, a heavy
atom derivative was prepared. A crystal was soaked for 1 h in 2 µl of reservoir solution
containing 0.06% C10E5 and 10 mM of the heavy atom compound. Anomalous signals
were calculated using SCALEPACK. The KAu(CN)2 data set showed the highest
anomalous signal with a total χ2 of 4.5 (10 in the lowest resolution shell and 1.5 in the
highest resolution shell). For convenience and due to the presence of ice rings, the data
were processed to only 3.95 Å resolution. Shake and Bake (DREAR/SnB package)
(Weeks & Miller, 1999) was used to find the gold atom positions.Two sites were found;
one Au(CN)2
- was close (~3 Å) to Phe27, which is located close to the trimer axis.The
distances between three gold peaks was ~6.8Å.The second peak was found close to the
backbone of Ser144. Phases were subsequently calculated using MLPHARE
(Collaborative Computational Project, 1994) to 4.0 Å resolution.This yielded an R-cullis
of 0.79.With density modification in CNS (Brunger et al., 1998), phases were extended
to 2.55 Å resolution using the native dataset. Model building was performed using the
program O (Jones et al., 1991), and the structure was refined using simulated annealing
and individual B-factor refinement using REFMAC5 (Murshudov et al., 1999).
Results
Refolding and quaternary structure of NspA
NspA was overproduced without its signal sequence in E. coli, which resulted in the
formation of NspA protein aggregates (inclusion bodies). After solubilization of these
inclusion bodies, NspA was refolded in a buffer containing the detergent
DodMe2NprSO3. Folding was monitored by semi-native SDS-PAGE. OMPs are
generally heat-modifiable, i.e. folded monomers run faster in SDS-PAGE gels than heat-
denatured proteins. In contrast, we observed that NspA migrated slower in the gel after
refolding. The denatured protein migrated at a mass of ~18 kDa, whereas the folded
protein migrated at 22 kDa, which agrees well with the electrophoretic mobility of native
NspA isolated from neisserial membranes (Moe et al., 1999).To investigate whether the
reduced electrophoretic mobility of folded NspA is due to dimerization, we performed
analytical ultracentrifugation experiments as well as chemical cross-linking. Both
methods (data not shown) as well as the crystal structure (see below) strongly indicated
that NspA is a monomer in a detergent-containing solution.
Structure solution
The NspA structure was solved with the single-wavelength anomalous dispersion
phasing method using KAu(CN)2. The refined model contained one monomer (155
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amino acids), five partial C10E5 molecules, one sulfate ion, one ethanolamine, and nine
water molecules in the asymmetric unit and had a crystallographic R-factor of 22.2% and
an Rfree of 25.8% for data in the 30-2.55 Å resolution range. For the side chains Glu1,
Lys53 and Lys79, no electron density was observed and therefore these were omitted from
the Protein Databank Bank file. The Ramachandran plot shows 92.4% of the ϕ/φ
combinations in the most favoured regions, 6.1% in the additionally allowed regions and
0.8% (residue Asn38 and Thr138, which are present in T1 and L4, respectively) in the
disallowed regions. The overall temperature factor is 40 Å2. Table 1 summarizes the
statistics of the crystallographic data and refinement. The crystal packing consisted of
crystallographic trimers, which were packed in alternating directions, in such a way that
the upper part of the molecule that faced up made contacts with the upper part of a
symmetry-related molecule that faced down.
Overall structure
NspA (Figure 5.1A) consists of an eight-stranded antiparallel β-barrel with a height
of ~50 Å and a main chain diameter of ~20 Å. It has a shear number of 10 with β-strands
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Figure 5.1 Overall structure of
NspA. A, a ribbon representation of
NspA. Aromatic residues located at the
membrane boundaries are drawn by ball-
and-stick model. Parts of the C10E5
molecules for which electron density was
observed are shown in light grey bonds.
Membrane boundaries are indicated by
the black lines. B, topology plot of NspA.
Amino acids are shown in one-letter
code. Residues present in β-strands are
shown as squares. Other residues are
presented as circles. Side chains of residues
that are shaded light grey point to the
outside of the barrel. Extracellular loops
are labelled L1 to L4 and the periplasmic
turns T1 to T3.The dashed line indicates
the hydrogen-bonding register within the
β-barrel. Panel A from this figure and
figure 2C and figure 3 were prepared
using Bobscript (Esnouf, 1999) and
Raster3D (Merrit & Murphy, 1994).
A
B
having an angle of ~40° with respect to the barrel axis. In general, OMPs contain short
turns at the periplasmic side of the protein and longer loops at the extracellular side with
the N and C termini located at the periplasmic side (see, for example, Refs. (Koronakis
et al., 2001; Prince et al., 2002;Vandeputte-Rutten et al., 2001)).The four long loops of
NspA are therefore likely to be located at the extracellular side of the membrane. Like
other OMPs, NspA contains two rings of aromatic residues (Figure 5.1A) that flank both
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Figure 5.2 NspA viewed from the periplasmic side and the extracellular side. A,
bottom view (periplasmic side) and B, top view (extracellular side), showing the molecular surface.
A, the centre is positively charge and B, the centre contains a hydrophibic groove. Loops are
indicated with L1 to L4. Some residue positions are indicated by one-letter code. C, stereo
representation of the NspA β-barrel as Cα-trace, in light grey, viewed from the top. Residues that
are within a distance of 4.5 Å to the detergent molecule in the crystal structure are shown in ball-
and-stick model and are labelled by one-letter code.A complete C10E5 detergent molecule is shown
in dark grey, and the electron density observed in the 2Fo - Fc map is shown as chicken wire around
the detergent molecule. Figures 2A and 2B were prepared using GRASP (Nicholls et al., 1991).
A
C
B
sides of the membrane and may stabilize the position of the barrel in the membrane
(Schulz, 2000).The lower ring contains 7 aromatic residues, whereas the upper ring is less
well defined. Located on top of the upper aromatic ring is a rim of mainly basic residues
that contains 7 lysines and 3 arginines (Figure 5.1B), a feature also found in other OMPs
(Zeth et al., 2000). Four detergent (C10E5) molecules are present at the sides of the barrel
(Figure 5.1A).Two of them are present at the interfaces of the crystallographic trimer,
which indicates that NspA is probably not a trimer in solution.The inside of the β-barrel
harbours an extensive hydrogen-bonding network as well as cavities, but there is no pore
through which ions or other molecules could be transported. The periplasmic side of
NspA is mainly basic in the centre with 5 positively charged residues residing in the
middle and some aspartates further away from the β-barrel axis (Figure 5.2A).The four
extracellular loops of NspA form a long groove at the top of the molecule, which is
highly hydrophobic (Figure 5.2B). Interestingly, we observed additional electron density
at the location of this hydrophobic groove, in the 2Fo - Fc and Fo - Fc omit-electron
density maps of NspA, which probably corresponds to part of a C10E5 detergent
molecule (Figure 5.2C).
Loop structures
NspA contains four long extracellular loops, which are well conserved among the
different neisserial strains.The loops have relatively low temperature factors, allowing for
accurate determination of their conformations. Loops 2 and 4 show some uncommon
features compared to the more standard β-hairpin loops seen in β-sheet structures. In the
case of loop 2, this could be the result of crystal contacts with the same loop from five
other symmetry-related NspA molecules (Figure 5.3A). However, the presence of a
conformation-restraining proline in the middle of the extremity of the loop might
indicate that loop 2 indeed has an uncommon conformation in the native NspA
structure. In loop 4, adjacent residues, Gly134 and Lys135 in strand 7 and Lys140 and
Asn141 in strand 8, are directed outwards from the barrel. Loops 1 and 3 both adopt a
2:4 tight β-hairpin conformation. Loop 3 (Figure 5.3A) contains 2 glycine residues,
which have a large degree of freedom for backbone angles, at its extremity. The
conformation of the loop seems to be stabilized by a hydrogen bond between a side chain
oxygen of Asp94 and the backbone nitrogen of Gly97. Due to the presence of two well
exposed aspartates, Asp94 and Asp99, the loop is negatively charged.This is in contrast
with the overall positive charge of NspA, which has a theoretical isoelectric point of 9.64.
Homology of NspA to other outer membrane proteins
Three other OMP structures that contain eight β-strands have been solved before, i.e.
the crystal structures of OmpA (Pautsch & Schulz, 1998) and OmpX (Vogt & Schulz,
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1999) and the solution structure of PagP (Hwang et al., 2002), all from E. coli.We searched
for more structural homologs of NspA in the Protein Data Bank using the program DALI
(Holm & Sander, 1993).This search revealed OmpA and OmpX with the highest z scores
of 17.8 and 12.9, respectively, and 144 and 139 Cα-atoms of NspA overlay with the Cα-
atoms of OmpA and OmpX with root-mean-square deviations of 2.5 Å and 3.4 Å,
respectively.The structure of NspA resembles that of OmpA most, probably because the
OmpA β-barrel also has a shear number of 10, whereas the shear number of OmpX is 8.
The third protein found by the DALI search was a soluble bacterial protein,
quinohemoprotein amine dehydrogenase from Paracoccus denitrificans (Datta et al., 2001),
a part of which forms of an eight-stranded β-barrel. Using the DALI program, we also
found that 126 Cα-atoms of NspA can be superpositioned on OpcA (Prince et al., 2002),
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Figure 5.3 Structure of loops 2 and 3. A, loop 2 in grey sticks and with labels shown
together with five symmetry-related loop 2s, which are shown as coils. Residues in the
symmetry-related loops (labelled 2-6) that make hydrogen bonds to residues in the original
(labelled 1) are shown by ball-and-stick. B, stereo representation of a ball-and-stick model of a
part of the immunodominant loop 3. Residues are labelled, and one of the hydrogen bonds is
indicated by a dotted line.
A
B
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Figure 5.4 Sequence alignment. Alignment of NspA from strain H44/76 with an Opa protein
from N. meningitidis serogroup A strain B494 (Opa Nm, GenbankTM accession number
AAC45976), with a homologous OMP from H. influenzae (Opa Hi, GenbankTM accession
number AAC23104) and with an OMP from P. multocida (Opa Pm, GenbankTM accession number
AAK03109). Fully conserved residues are shown with a light grey background. Residues that make
contact to the detergent molecule in the groove at the top of NspA are shown in white letters with
a dark grey background. Arrows indicate the β-strands in NspA.`
a 10-stranded β-barrel from N. meningitidis, with an root-mean-square deviation of only
3.0 Å and a z score of 9.3. Similarly, another 10-stranded β-barrel, OmpT from E. coli
(Vandeputte-Rutten et al., 2001), superpositions on NspA with 122 residues with an
root-mean-square deviation of  3.8 Å and a z score of 9.4.Although these scores reflect
the overall similarities between these 8- and 10-stranded β-barrels, no further remarkable
similarities between NspA on the one hand and OpcA or OmpT on the other hand
could be detected.
NspA shares the highest sequence homology (~38.7% identity) to the members of the
neisserial Opa protein family of adhesins (Figure 5.4). No three-dimensional structure has
been solved for these important molecules, but Marlorny et al. (Malorny et al., 1998)
predicted the topology of Opa. Residues that are present in the membrane-spanning β-
strands of NspA are highly conserved between NspA and Opa, particularly the residues
that are located on the inside of the β-barrel. It is therefore likely that the structures of
Opa and NspA are highly similar in the membrane-spanning region.A major difference
between NspA and Opa is the length of the extracellular loops, which are much longer
in Opa proteins. Using the sequence similarity between Opa and NspA, we refined the
previously predicted Opa topology model (Figure 5.4). In the previous topology model,
turn 2 was exceptionally long. In the crystal structure of NspA, this turn is almost as short
as the other two turns. Based on the sequence homology between Opa and NspA, it is
likely that the fourth strand in the previously predicted topology model has to be shifted
toward the extracellular side by 8 residues.
NspA has, in addition, high sequence similarity (~35% identity) with two non-
characterized Opa proteins from Haemophilus influenzae and Pasteurella multocida (Figure
5.4).The loops from the H. influenzae and P. multocida proteins are more comparable in
length with the loops in NspA than to those of the neisserial Opa proteins. Since the
hydrophobic groove harbouring a detergent molecule is a remarkable feature of the
NspA structure, we examined specifically whether the hydrophobic residues contacting
the detergent molecule are conserved in the H. influenzae and P. multocida proteins.
Although none of them was fully conserved, most of the substitutions involved
replacements by other hydrophobic residues, especially in the cases of the residues that
are located most centrally.
Discussion
There is an obvious need for a vaccine that offers protection against diverse group B
meningococcal strains. As described in the Introduction of this chapter, this vaccine
should consist of non-capsular components, such as the OMPs present in outer
membrane vesicles (OMVs).The major hurdle in development of such a vaccine has been
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the fact that the meningococcus possesses a huge capacity to change its outer surface by
phase and antigenic variation of many of its OMPs. For this reason, the OMV vaccines
tested so far were very effective against their homologous strains but offered far less
protection against heterologous strains. Therefore, novel vaccine candidates that are
conserved among strains and will likely confer broad protection need to be identified.
One very promising vaccine candidate is NspA, which is remarkably conserved among
neisserial strains. The relatively low amount of NspA generally present in OMVs may
prevent a sufficiently high immune response against this protein in vaccines. However,
Moe et al. (Moe et al., 2002) have recently shown that sequential immunization with
OMVs that were heterologous for the major immunodominant OMPs, but all contained
NspA, resulted in protective immunity that was at least partly mediated by bactericidal
anti-NspA antibodies. Thus, given in the correct formulation, NspA could be a very
important novel vaccine component. Our present study aids in the further development
of NspA-based vaccines. For example, we developed efficient procedures to produce
NspA and to refold it in vitro into its native conformation. This refolded NspA can be
used in vaccine formulations.As an alternative strategy, the use of peptide vaccines can be
considered. In general, bactericidal antibodies are directed to conformational epitopes,
which are, in OMPs, typically located in the extracellular loops. In a previous study, we
described that bactericidal antibodies could not be elicited in mice with a linear peptide
derived from an epitope from PorA. However, based on the crystal structure of a peptide
containing a sequence derived from a PorA epitope in complex with a Fab fragment of
a bactericidal antibody, a conformationally restrained peptide was designed. With this
peptide, a specific bactericidal immune response could be elicited, demonstrating the
value of structural information (Oomen et al., 2003). In NspA, loop 3 is the longest of
the four loops and is probably, as in the crystal structure, most exposed in vivo. Hou et al.
(Hou et al., 2002) have shown that loop 3 is an important target for bactericidal
antibodies directed against recombinant NspA.The structure of the extracellular loops,
particularly loop 3, may greatly aid in the design of peptide vaccines.
The function of NspA is not known yet, although experiments performed by Moe et
al. (Moe et al., 2001) suggest that NspA is at least not necessary for causing bacteremia in
infant rats. Nevertheless, the observation that NspA is highly conserved and is expressed
in all neisserial strains tested so far suggests that its function is important. Based on the
sequence similarity of NspA to Opa proteins, which are adhesins facilitating colonization
of the human naso-pharynx, it could be possible that NspA is an adhesin as well.
However, preliminary experiments, in which we measured the adherence of an E. coli
strain overexpressing NspA to primary human corneal cells, do not support this idea.
Either NspA is not adhesin or its adhesive function is blocked on the surface of E. coli,
possibly due to the long lipopolysaccharides. It is interesting that the structure of NspA
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contains a remarkable hydrophobic groove at the top of the molecule, which harbours a
detergent molecule. Among the crystal structures of the closed OMPs, i.e. OmpA,
OmpX, PagP, OmpT, OpcA and OMPLA (Snijder & Dijkstra, 2000), only OmpX also
contains a central hydrophobic patch at the extracellular side of the molecule, but it does
not form such an extended groove as in NspA. Possibly, NspA could bind a lipid-like
molecule, such as a membrane lipid, in vivo, thereby possibly playing a role in the invasion
of N. meningitidis into host cells by interacting with the lipid bilayer of these cells. Future
studies, which can now be guided by the elucidated structure of NspA, will bring more
insight into the function of NspA.
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Summary
The proteins found in the outer membrane of Gram-negative bacteria perform a
wide variety of functions. Some of these OMPs function as adhesins that mediate
adhesion to receptors on host cells facilitating entry of the bacterium into the host.
Others function as pores that transport substances varying from ions to whole proteins.
Only a small number of OMPs are enzymes that are involved in processes such as the
degradation of phospholipids or cleavage of proteins. Despite their different functions,
OMPs possess a general structure. They consist of β-strands, that are arranged into a
barrel-like structure, referred to as β-barrel, and in addition contain long loops at the
extracellular side and short turns at the periplasmic side.OMPs are particularly interesting
for biomedical purposes: (1) OMPs are found in the outer membranes of pathogenic
Gram-negative bacteria and are often implicated as virulence factors. (2) They are
surface-exposed and therefore suitable for vaccine development. Structural information
obtained techniques such as with crystallography or NMR is important to gain insight
into the function of OMPs and in addition provides detailed information on regions that
may be targeted for drug or vaccine design.
In this thesis the crystal structures of the OMPs, OmpT from Escherichia coli and NspA
from Neisseria meningitidis, are described. OmpT serves as a paradigm for the omptin
family of outer membrane proteases. A number of omptin members are implicated as
virulence factors. One example is Pla from Yersinia pestis, which increases the virulence
of this bacterium, leading to bubonic plague. NspA from N. meningitidis is a promising
vaccine candidate, as it is conserved among different strains of N. meningitidis and Neisseria
gonorrhoeae. NspA shares significant sequence homology with Opa proteins, which are
important adhesins of N. meningitidis.
OmpT cleaves substrates between two consecutive basic amino acids. Its activity is
dependent on the presence of lipopolysaccharide (LPS). OmpT has traditionally been
classified as a novel member of the serine protease family.The observations that OmpT
contains no cysteines, that its activity has a high pH optimum and cannot be inhibited by
EDTA, suggest that OmpT is not a cysteine protease, aspartic protease or metalloprotease.
The classification of OmpT as a serine protease is, however, controversial. Indeed, site
directed mutagenesis studies showed that mutation of Ser99 and His212, which are part
of the putative catalytic triad led to a significant reduction of catalytic activity. In contrast,
commonly used serine protease inhibitors fail to inhibit OmpT activity significantly.
Chapter 2 describes the crystal structure of OmpT at 2.6 Å resolution. It is the first
structure of an outer membrane protease. OmpT forms a 10-stranded β-barrel, which
protrudes far into the extra-cellular space, comparable with FhuA. The barrel is
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constricted above the membrane spanning region. The structure is informative in two
respects. It shows that, indeed, OmpT has an unusual catalytic site and it reveals a putative
LPS binding site.The catalytic site is located in a large, negatively charged groove, at the
extracellular side of the molecule. In this active site Ser99 and His212 are located more
than 8 Å apart, making it unlikely that they participate in one catalytic triad. Instead,
based on the structure we propose a novel catalytic site. In chapter 3, site directed
mutagenesis studies of the conserved acidic residues are described. Mutation of any of the
three aspartic acid residues,Asp83,Asp85 and Asp210, resulted in a reduction of activity
comparable to the His212Ala mutant (~10,000 fold). Furthermore, mutation of Glu27,
Asp97 and Asp208 resulted in significant reduction in activity by ~10 fold. Asp83 and
Asp85 are located in close proximity to each other in the crystal structure, forming a
couple at one side of the active site groove, and face Asp210 and His212, which form a
couple on the other side of the groove.Therefore, based on the structure as well as the
mutagenesis data, we propose a novel catalytic site for OmpT, consiting of Asp83,Asp85,
Asp210 and His212. In the putative mechanism a water molecule, held in place by Asp83,
is activated by the His212-Asp210 dyad, similar to activation of the catalytic serine in
serine proteases.The Asp83-Asp85 couple forms the oxyanion hole in a similar fashion
as is proposed for aspartic proteases, in which the aspartic couple donates a proton to the
oxyanion in the tetrahedral transition state.
The confirmation of our hypothesis awaits the elucidation of a crystal structure of
OmpT in complex with a substrate analogue or inhibitor. Attempts to solve a structure
of OmpT in complex with a substrate analogue have thus far failed. However, we were
able to solve a crystal structure of OmpT in complex with zinc, which is a strong
inhibitor of OmpT activity.The results are described in chapter 4. In order to obtain
an OmpT/Zn2+ complex structure, we soaked an OmpT crystal with ZnCl2. In both
OmpT molecules in the asymmetric unit, two Zn2+ ions bound in the catalytic site,
occupying in total four different binding sites. Binding of Zn2+ induces conformational
changes in the active site, bringing the Asp83-Asp85 and Asp210-His212 couples more
than 2 Å closer to each other. Additionally, binding of Zn2+ results in high disorder of
the extracellular loops. The four Zn2+ ions in the asymmetric unit are coordinated
differently. Interestingly, the two Zn2+ ions that have the highest coordination numbers
are both liganded to Asp83. Zinc acts as a non-competitive inhibitor, which means that
a substrate can bind but catalysis is inhibited. Therefore, it is likely that Asp83 is not
important for substrate binding, but is involved in the catalytic process, like we propose.
The constellation of the active site observed in the crystal structure, in which the
proposed four catalytic residues lay in close proximity to each other, seems to be
compatible with activity. It is possible however, that the crystal structure of OmpT
described in chapter 2 represents an inactive form of OmpT. Catalytic activity of
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OmpT is dependent on the presence of LPS, whereas this molecule is lacking in the
structure. A consensus three-dimensional LPS binding motif, consisting of four basic
amino acids, was recently proposed, based on the crystal structure of the OMP FhuA in
complex with LPS. The structure of OmpT reveals a similar binding site for LPS,
consisting of three basic amino acids.The location of this site, at a considerable distance
from the active site, close to the membrane-spanning region, suggests that LPS does not
participate directly in the catalytic process. This is supported by observation that LPS
molecules lacking core sugars are sufficient to allow catalysis by OmpT. Possibly, binding
of LPS to OmpT results in a slight conformational change of the barrel, which affects the
structure of the catalytic site. The OmpT/ Zn2+ complex structure supports the
viewpoint that conformational changes likely occur near the active site of OmpT.
Chapter 5 describes the crystal structure of neisserial surface protein A (NspA), an
outer membrane protein from N. meningitidis. NspA is a potential vaccine candidate
against N. meningitidis, because it is highly conserved among meningococcal strains and it
induces bactericidal antibodies. These antibodies are directed towards the extracellular
loops of NspA, especially against loop 3.The function of NspA is unknown, but because
it is highly conserved, it is thought to be important.The structure of NspA, which forms
an eight-stranded β-barrel, revealed two interesting features. Firstly, the structure shows
the exact conformation of the loop 3, which is the longest loop and which forms an
epitope against which bactericidal antibodies are directed.This conformation may form
the basis of a rational structure-based design of cyclic peptides that mimic the structure
of the loop and can potentially be used as peptide vaccines against N. meningitidis strains,
including serogroup B, for which no vaccine is available yet.A second remarkable feature
of the NspA structure is the presence of a long hydrophobic groove at the extracellular
side of NspA, in which a detergent molecule is bound.This suggests that NspA can bind
hydrophobic ligands, such as lipids.Although NspA is not involved in causing bacteremia
in the blood in infant rats, NspA might be important in another life stage of the
meningococcus. NspA could be involved in adhesion to or invasion into human
epithelial cells by binding to hydrophobic ligands, such as the membrane lipids of host
cells.
In summary, the structures of the two outer membrane proteins, OmpT and NspA
described in this thesis, provide valuable information on their functions and provide
starting points for the design of drugs and vaccines, respectively.
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Samenvatting
Eiwitten die aanwezig zijn in de buitenmembraan van Gram-negatieve bacteriën
hebben een variëteit aan functies. Een aantal van deze eiwitten functioneert als
“adhesinen”, welke zorgen voor de aanhechting aan receptoren van gastheercellen, zodat
de bacterie kan binnendringen in de gastheer.Anderen vormen poriën die zorgen voor
het transport van ionen, eiwitten, etc. Een klein aantal buitenmembraan eiwitten zijn
enzymen die betrokken zijn bij processen, bijvoorbeeld de afbraak van fosfolipiden of
eiwitten. Ondanks de verschillende functies van buitenmembraan eiwitten, bezitten deze
eiwitten toch een gemeenschappelijke structuur. Ze bestaan uit β-strands, die zo
gerangschikt liggen dat ze een ton-achtige structuur vormen. Deze structuren worden
“β-barrels” genoemd, en hebben lange loops aan de extracellulaire zijde and korte turns
aan de periplasmatische zijde. Buitenmembraan eiwitten zijn bijzonder interessant voor
biomedische doeleinden: (1) Ze zijn aanwezig in de buitenmembraan van ziekte-
verwekkende Gram-negatieve bacteriën en zijn vaak betrokken bij ziekte verwekking. (2)
Ze zijn blootgesteld aan de omgeving buiten de bacterie en zijn daarom geschikt voor
vaccin ontwikkeling. Structurele informatie verkregen met technieken zoals
kristallografie en NMR is belangrijk om meer inzicht te verkrijgen in het functioneren
van buitenmembraan eiwitten and geeft bovendien gedetailleerde informatie over de
delen die gebruikt zouden kunnen worden voor het ontwikkelen van medicijnen of
vaccins.
In dit proefschrift worden de structuren van twee buitenmembraan eiwitten, OmpT
van Escherichia coli en NspA van Neisseria meningitidis beschreven. Escherichia coli is een
bacterie die normaal in de darmen van de mens voorkomt. In sommige gevallen kan deze
bacterie blaasontsteking veroorzaken. Neisseria meningitidis is een bacterie die
hersenvliesontsteking kan veroorzaken. OmpT fungeert als paradigma voor een familie
van buitenmembraan proteases, omptins genoemd. Een aantal leden van deze familie is
betrokken bij ziekteverwekking. Een goed voorbeeld is Pla van Yersinia pestis, welke de
virulentie verhoogt van deze bacterie die de pest veroorzaakt. NspA van N. meningitidis is
een veel belovende vaccinkandidaat, omdat het een eiwit is dat geconserveerd is tussen
verschillende Neisseria stammen. NspA vertoont ook gelijkenis met Opa eiwitten, welke
belangrijk zijn voor de aanhechting van N. meningitidis aan menselijke cellen.
OmpT knipt substraten tussen twee opeenvolgende positief geladen aminozuren. De
activiteit van OmpT is afhankelijk van de aanwezigheid van lipopolysaccharide (LPS),
een belangrijke component van de buitenmembraan. OmpT was oorspronkelijk
geclassificeerd als een nieuw lid van de serine protease familie. Het feit dat OmpT geen
cysteines bezit, dat het actief is bij hoge pH en dat de activiteit niet geremd kan worden
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door EDTA, suggereert dat OmpT geen cysteine protease, aspartaat protease of
metalloprotease is. De classificatie van OmpT als serine protease is nog steeds onderwerp
van discussie. Aan de ene kant hebben mutagenese studies laten zien dat mutaties van
serine 99 en histidine 212, welke deel uit maken van de mogelijk katalytische triade, zoals
verwacht tot een significante daling van activiteit leiden.Aan de andere kant kunnen veel
gebruikte serine protease remmers de activiteit van OmpT niet of nauwelijks remmen.
Hoofdstuk 2 beschrijft de kristalstructuur van OmpT, opgelost tot 2.6 Å resolutie
(=oplossend vermogen), de eerste structuur van een buitenmembraan protease. OmpT
vormt een β-barrel met tien β-strands, die ver naar buiten uitsteekt. De β-barrel is
gesloten boven het gedeelte dat in de membraan zit. De structuur geeft informatie in
twee opzichten. Hij laat zien dat OmpT inderdaad een ongewoon katalytisch centrum
heeft, en onthult een mogelijke LPS bindingsplaats. Het katalytisch centrum ligt in een
grote, negatief geladen groeve, aan de buitenzijde van het molecuul. In dit actieve
centrum liggen Ser99 en His212 meer dan 8 Å van elkaar vandaan, wat het
onwaarschijnlijk maakt dat ze deel uitmaken van één en dezelfde katalytische triade. In
hoofdstuk 3, worden mutagenese studies aan de geconserveerde zure residuen
beschreven. Mutatie van elk van de drie aspartaten,Asp83,Asp85 en Asp210, resulteert in
een verlaging van de activiteit met zo’n 10.000 keer.Verder resulteert de mutatie van
Glu27, Asp97 en Asp208 in een tienvoudige verlaging van activiteit. Asp83 en Asp85
liggen dicht bij elkaar in de kristalstructuur en vormen een koppel aan de ene kant van
het actieve centrum.Aan de andere kant van het centrum, vormen Asp210 en His212 een
koppel. Gebaseerd op de kristalstructuur en de mutagenese data, stellen we een nieuw
katalytische centrum voor OmpT voor, die bestaat uit Asp83,Asp85,Asp210 en His212.
In het voorgestelde mechanisme wordt een watermolecuul, dat op zijn plaats wordt
gehouden door Asp83, geactiveerd door het His212-Asp210 koppel, zoals bij activatie van
de katalytische serine in serine proteases. Het Asp83-Asp85 koppel vormt de “oxyanion”
holte, zoals voorgesteld voor aspartaat proteases, waarin het aspartaat koppel een proton
doneert aan het oxyanion in het tetrahedrale transitie stadium.
Om onze hypothese te bevestigen is het nodig om de kristalstructuur van OmpT in
complex met een substraatanaloog of remmer te bepalen. Pogingen om zo’n structuur te
bepalen zijn tot nu toe niet succesvol geweest.We hebben echter wel de kristalstructuur
van OmpT in complex met zink, een sterke remmer van OmpT activiteit, kunnen
bepalen. De resultaten van deze structuur zijn beschreven in hoofdstuk 4. Om een
structuur van een OmpT/Zn2+ complex te verkrijgen hebben we een OmpT kristal
gedrenkt in ZnCl2. In de asymmetrische eenheid bevinden zich twee OmpT moleculen
die beide twee Zn2+ ionen hebben gebonden in het katalytisch centrum. Deze Zn2+
ionen bezetten in totaal vier verschillende binding plaatsen. Het binden van Zn2+ door
OmpT veroorzaakt aanzienlijke veranderingen in de structuur in en rond het actieve
Samenvatting
104
centrum, waardoor de Asp83-Asp85 en Asp210-His212 koppels meer dan 2 Å dichter bij
elkaar komen.Verder veroorzaakt binding van Zn2+ wanorde in de extracellulaire loops.
De vier Zn2+ ionen in de asymmetrische eenheid zijn verschillend gecoördineerd. De
twee Zn2+ ionen die het hoogste coördinatie nummer hebben zijn beide gebonden aan
Asp83. Zink is een non-competitieve remmer, wat betekent dat een substraat weliswaar
kan binden, maar dat katalyse wordt geremd. Daarom is het waarschijnlijk dat Asp83 niet
belangrijk is voor substraatbinding, maar betrokken is bij het katalytisch proces, zoals wij
voorstellen.
De rangschikking van de aminozuren in het actieve centrum zoals waargenomen in
de kristalstructuur, waarin de katalytische residuen dicht bij elkaar liggen, lijkt compatibel
met activiteit. Het is echter mogelijk dat de kristalstructuur zoals beschreven in hoofdstuk
2 een inactieve vorm van OmpT weergeeft. De katalytische activiteit is afhankelijk van
de aanwezigheid van LPS, terwijl dat molecuul niet aanwezig is in de structuur. Op basis
van de structuur van het buitenmembraan eiwit FhuA in complex met LPS, is een
“consensus” drie-dimensionaal LPS bindingsmotief, dat bestaat uit vier positief geladen
aminozuren, voorgesteld. De structuur van OmpT suggereert een soortgelijke
bindingsplaats voor LPS, die bestaat uit drie positief geladen aminozuren. De locatie van
deze bindingsplaats, een aanzienlijke afstand van het actieve centrum verwijderd,
suggereert dat LPS niet direct deel neemt aan het katalytisch proces. Dit wordt nog
versterkt door de observatie dat LPS moleculen die “core” suikers missen nog steeds
OmpT activeren. Het is mogelijk dat binding van LPS aan OmpT resulteert in een
geringe structurele verandering, die de structuur van het katalytisch centrum beïnvloed.
De OmpT/Zn2+ complex structuur versterkt het idee dat structurele veranderingen
mogelijk optreden dichtbij het actieve centrum van OmpT.
Hoofdstuk 5 beschrijft de kristalstructuur van neisserial surface protein A (NpsA),
een buitenmembraan eiwit van Neisseria meningitidis. NspA is een goede vaccin kandidaat
tegen verschillende Neisseria stammen omdat het goed geconserveerd is tussen Neisseria
stammen en omdat het bacteriedodende antilichamen opwekt. Deze antilichamen zijn
gericht tegen de extracellulaire loops van NspA, in het bijzonder tegen loop 3. De functie
van NspA is onbekend, maar omdat het eiwit zo goed geconserveerd is, is de functie
waarschijnlijk belangrijk. De structuur van NpsA, welke een β-barrel met acht β-strands
vormt, onthult twee belangrijke eigenschappen.Ten eerste, de structuur onthult de exacte
structuur van loop 3, de langste loop. Deze structuur kan gebruikt worden voor het
ontwerpen van cyclische peptiden die gebruikt zouden kunnen worden als peptide
vaccins tegen N. meningitidis stammen, waaronder serogroep B, waartegen nog geen
vaccin beschikbaar is. Een tweede bijzondere eigenschap van NspA is de aanwezigheid
van een lange hydrofobe groeve aan de extracellulaire zijde van NspA, waar in de
structuur een detergent molecuul in gebonden zit. Dit suggereert dat NspA hydrofobe
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liganden kan binden, bijvoorbeeld lipiden. Hoewel NspA niet betrokken is bij het
vermenigvuldigen van de meningococ in het bloed van jonge ratten, is NspA mogelijk
belangrijk in een ander stadium in het leven van de meningococ. NspA kan bijvoorbeeld
betrokken zijn bij adhesie of bij invasie in menselijke epitheel cellen door te binden aan
hydrofobe liganden, zoals membraan lipiden van de gastheer cellen.
Samengevat, de structuren van de twee buitenmembraan eiwitten, OmpT en NspA
beschreven in dit proefschrift, geven veel informatie over hun functies en vormen een
goed begin voor het ontwerpen van medicijnen en vaccins, respectievelijk.
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